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ABSTRACT 
 Research suggests that the cyclic AMP (cAMP) signaling pathway is implicated in the 
development of alcoholism.  Previous work in our laboratory has demonstrated that alcohol 
enhances the activity of adenylyl cyclase (AC) in an isoform specific manner; human type 7 AC 
(AC7) is most enhanced by ethanol as measured by cAMP accumulation assay in whole cells. 
We hypothesize that alcohol enhances AC activity by directly interacting with the protein and 
that alcohol effects on AC can be studied using recombinant AC expressed in bacteria.  Our 
objectives include: 1) design and optimization of the conditions for protein expression and 
protein purity for recombinant AC proteins; 2) identification of the importance of each 
cytoplasmic domain to the alcohol effect through chimeric analysis; and 3) investigation of the 
interaction between alcohol and AC stimulators such as MnCl2, forskolin, and Gsα through 
concentration-response experiments.  To examine these objectives, we expressed in bacteria, and 
purified recombinant AC proteins carrying the C1a and/or C2 domains of AC2, AC7, and AC9. 
We present the optimal conditions for the expression and purification of multiple recombinant 
AC proteins and show that purified recombinant AC proteins retain enzymatic activity and 
alcohol responsiveness.  Through chimeric analysis, we found that the C1a and C2 domains both 
contribute to the alcohol effect on AC7, however, AC7 C1a may play a stronger role. We also 
find that recombinant AC responds to alcohol differently under varied conditions of AC 
activation by MnCl2, forskolin, and Gsα.  Through concentration-response experiments we found 
that there is some interaction between alcohol and forskolin or Gsα, but alcohol does not appear  
to be competing with forskolin or Gsα at an allosteric site.  Overall the results suggest that 
alcohol interacts with AC proteins directly, independent of stimulants examined, and causes a 
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conformational change, which results in either enhancement or inhibition depending on 
stimulation conditions. 
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CHAPTER 1. 
INTRODUCTION 
Alcohol Use and Abuse 
Alcohol use is common in the United States and in most countries around the world.  The 
effects of alcohol use are wide ranging; many individuals can use alcohol with no development 
of problematic symptoms, many individuals develop long term problems and pathologies as a 
result of alcohol use, and there is even evidence to suggest that some alcohol use may be 
beneficial.  The National Institute on Alcohol Abuse and Alcoholism (NIAAA) was established 
to address the health implications of alcohol use with a yearly budget of approximately $460 
million dollars appropriated in 2012.  According to the NIAAA, 51.5% of US adults age 18 and 
above are regular drinkers, defined as greater than or equal to 12 drinks per year.  One drink is 
defined as 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of 80-proof liquor.  Per capita 
ethanol consumption was estimated at 2.26 gallons in 2010.  Alcohol use is implicated in deaths 
both directly and indirectly.  In 2010, 25,440 alcohol-induced deaths were reported that were not 
the result of traffic accidents or homicide (Murphy, Xu, & Kochanek, 2012).  According to the 
Centers for Disease Control and Prevention, alcohol-impaired driving accounted for 10,228 
deaths in 2010 which accounted for 31% of total traffic deaths that year.  Furthermore, in 2010, 
more than 1.4 million drivers were arrested for impaired driving under the influence of alcohol or 
narcotics and approximately 112 million adults admit to alcohol-impaired driving.  The overall 
costs of alcohol abuse to the US, accounting for health care costs, productivity impacts, motor 
vehicle accidents, crime, fire, and social welfare costs, equate to approximately $185 billion 
annually (National Institutes of Health, 2000).  
The defining factors between alcohol use, alcohol abuse, and alcoholism are 
characterized by volume, frequency, and duration of use.  Alcoholism is a general term used to 
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describe patterns of problematic alcohol drinking behaviors.  Specifically, the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) classifies 
pathological alcohol use as alcohol abuse or alcohol dependence.  Criteria for alcohol abuse 
requires one of the following in a 12-month period: recurrent alcohol use leading to the failure to 
fulfill obligations at work, home, or school; recurrent alcohol use leading to physically hazardous 
situations; alcohol-related legal problems; continued use of alcohol despite social or 
interpersonal problems caused by the effects of alcohol (American Psychiatric Association, 
2000).  Criteria for alcohol dependence requires three or more of the following in a 12-month 
period: the need for increased amounts of alcohol for desired effect; withdrawal syndrome; 
drinking larger amounts or for longer periods; persistent desire for alcohol or unsuccessful 
attempts to stop drinking; discontinued participation in social, occupational, or recreational 
activities due to alcohol use; large amount of time spent obtaining, using, or recovering from 
alcohol use; continued alcohol use despite physical or psychological problems caused by alcohol 
(American Psychiatric Association, 2000).       
Alcohol and the Brain 
 The function of alcohol on the brain is diverse and complex.  Alcohol affects many brain 
regions including the cerebral cortex, cerebellum, limbic system, ventral tegmental area, and 
nucleus accumbens (Zahr, Pitel, Chanraud, & Sullivan, 2010; Oscar-Berman & Marinković, 
2007).  The cerebral cortex innervates many other brain regions and is responsible for executive 
and cognitive functions as well as emotion.  Loss of cortical neurons is commonly observed with 
chronic alcohol use (Oscar-Berman & Marinković, 2007).  The cerebellum is mostly known for 
coordination of motor function.  However, recent research suggests the existence of several 
cerebral-cerebellar circuits that implicate the cerebellum in cognitive functions such as memory 
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and attention (Oscar-Berman & Marinković, 2007).  Like the cerebral cortex, neurodegeneration 
is also observed in the cerebellum following chronic alcohol use.  Alcohol’s effect on the 
cerebellum is thought to contribute to loss of impulse control, conflict processing, and 
disinhibition (Zahr et al., 2010).  The limbic system includes several brain regions including the 
thalamus, hypothalamus, cingulate gyrus, amygdala, hippocampus, and basal ganglia and is 
responsible for the regulation of memory and emotion.  The limbic system is also important for 
motivation.  Activation of the amygdala, important for motivation and emotional processing, is 
attenuated in alcoholics (Oscar-Berman & Marinković, 2007).  In addition to motivation and 
emotion, the hippocampus is implicated in the formation of memories.  The hippocampus is one 
of the only brain regions that continue to produce new neurons throughout the life span; this 
neurogenesis is reduced in alcoholics (Oscar-Berman & Marinković, 2007).  Chronic alcohol use 
can cause damage to the hypothalamus and is associated with memory loss, including both 
retrograde and anterograde amnesia (Oscar-Berman & Marinković, 2007).  Additionally, the 
hypothalamic-pituitary-adrenocortical (HPA) axis, implicated in the response to stress, is 
suppressed in chronic alcoholics (Oscar-Berman & Marinković, 2007).  The limbic system 
structures, along with the ventral tegmental area and the nucleus accumbens, make up the reward 
center in the brain.  Acute exposure to alcohol modulates the neural transmission in this brain 
circuit and chronic exposure has been shown to reduce the volume of these structures (Zahr et 
al., 2008).  What makes many of these particular brain regions susceptible to alcohol is the 
localization of the neurotransmitter systems within the groups of neurons.   
Neurotransmitters and neuromodulators which are primarily involved in the response to 
alcohol include glutamate, gamma-aminobutyric acid (GABA), glycine, serotonin, dopamine, 
adenosine, and opioids (Lovinger, 2008; Gass & Olive, 2012).  GABA is an inhibitory 
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neurotransmitter which works primarily through ligand-gated ion channels (LGIC), but can also 
act through G protein-coupled receptors (GPCR).  Alcohol increases activity of the GABAergic 
system through numerous mechanisms and the GABAergic system is implicated in both acute 
and chronic alcohol effects.  Acute effects of alcohol mediated by GABA include alcohol 
intoxication symptoms such as motor incoordination, anxiolytic effects, and sedation (Lovinger, 
2008).  With chronic and acute use, the increase in GABAergic transmission during alcohol 
exposure can lead to brain hyperexcitability during withdrawal from chronic alcohol use 
(Lovinger, 2008).  Glutamate is an excitatory neurotransmitter and also functions primarily with 
LGICs; however, there are some glutamate-linked GPCRs.  Acute alcohol use inhibits the 
glutamatergic system; this is thought to be partially responsible for the intoxicating effects of 
alcohol and associated memory impairment (Möykkynen & Korpi, 2012).  Inhibition of the 
glutamatergic system by chronic alcohol use leads to an up regulation of some glutamate 
receptors that can contribute to the brain hyperexcitability that occurs during alcohol withdrawal 
(Lovinger, 2008).  Glycine as a neurotransmitter has also been implicated in the response to 
alcohol.  Glycine receptors are also LGICs and are inhibitory to neural transmission.  Alcohol 
increases the effect of glycine at the glycine receptor (Perkins, Trudell, Crawford, Alkana, & 
Davies, 2010).  The effect of alcohol on the glycinergic system has been linked to modulation of 
ethanol intake, ethanol-induced sedation, and incoordination (Perkins et al., 2010).  Serotonin is 
mostly linked to GPCRs, but is also linked to one LGIC, both of these receptor types can be 
affected by alcohol.  The serotonergic LGIC, 5-HT3, is located on axon terminals responsible for 
the release of GABA.  Activation of the 5-HT3 results in the release of GABA which causes 
neural inhibition; alcohol potentiates the function of the 5-HT3 receptor (Lovinger, 1999) thus 
increasing neural inhibition which is implicated in intoxication.  Several other studies have 
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associated genetic polymorphisms in serotonin receptors with the development of alcoholism 
(Gass & Olive, 2012).  The neurotransmitter dopamine is linked only to GPCRs and is 
implicated in the reward and learning aspects of alcoholism (Lovinger, 2008).  Acute alcohol 
intake increases the release of dopamine in the brain and the rewarding effect of dopamine 
reinforces the consumption of alcohol (Lovinger, 2008).  Dopaminergic activity is suppressed as 
a result of chronic alcohol use; in order to compensate, the expression of some dopamine 
receptors are up-regulated; a process which may be responsible for alcohol seeking behaviors 
and the development of addiction (Gass & Olive, 2012).  Alcohol also affects adenosine, which 
is considered to be a neuromodulator and acts via GPCRs (Lovinger, 2008).  Acute alcohol 
intake increases adenosine driven cell signaling in neurons (Nagy, Diamond, Casso, Franklin, & 
Gordon, 1990).  Chronic alcohol intake down-regulates adenosine receptors in brain areas which 
are crucial for reward and addiction (Lovinger, 2008).  Opioid peptides are also considered to be 
neuromodulators and act on GPCRs; they are a contributing factor to the development of 
addiction in many drugs of abuse including alcohol.  Similar to the effect of alcohol on other 
neurotransmitters, acute alcohol use increases the release of opioid peptides and chronic alcohol 
use can modify opioid receptor expression (Olive, Koenig, Nannini, & Hodge, 2001).  
Naltrexone, a drug which is used in the treatment of alcoholism, is an opioid antagonist (Gass & 
Olive, 2012). 
 From a gross anatomical perspective, chronic alcohol use can result in brain atrophy 
(Harper & Kril, 1985; Chandrasekar, 2013).  Postmortem comparisons of alcoholic brains with 
control brains show significant brain atrophy in the alcoholic brain (Harper & Kril, 1985).  
Imaging studies have also shown significant loss of brain matter volume in alcoholics; 
particularly in those areas most affected by alcohol abuse such as the cerebral cortex, cerebellum, 
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and limbic system (Oscar-Berman & Marinković, 2007).  The cause of alcohol related brain 
atrophy is the loss of neurons by excitotoxicity (Chandrasekar, 2013).  Excitotoxicity occurs 
when neurons are hyperactivated, leading to excess influx of calcium which is toxic to the cell.  
The upregulation of some glutamate receptors during chronic alcohol use may contribute to the 
hyperactivation of neurons and eventual cell death (Chandrasekar, 2013). 
 Finally, at the molecular level, there is evidence that alcohol can directly influence some 
proteins in the brain.  Because ethanol is small in molecular structure, many traditional models 
for determining a “binding site” are not feasible.  In fact, many researchers suggest that alcohol 
does not follow the typical high affinity binding style that is seen with many other drugs of 
abuse, but instead may have multiple sites of action (Perkins et al., 2010).  Using alternative 
alcohols that are larger in molecular size, some groups have been able to analyze the structure of 
alcohol interacting with various ion channels which are present in the brain (Howard et al., 
2011).  LUSH proteins are odorant-binding proteins in the fruit fly Drosophila that are secreted 
into the fluid that bathes olfactory neurons.  LUSH proteins are responsible for the detection of 
alcohol in Drosophila (Bucci, Kruse, Thode, Alvarado, & Jones, 2006).  The structure of alcohol 
bound to LUSH was resolved by x-ray crystallography; a specific binding site was identified that 
consists of 3 amino acid residues which are also found in some ion channels that are known to be 
affected by alcohol (Kruse, Zhao, Smith, & Jones, 2003).  Many other alcohol binding or action 
sites have been proposed based on extensive mutagenesis studies, however, definitive evidence 
remains elusive due to the low affinity of physiologically relevant alcohols, which limits the 
success of structural analysis. 
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Alcohol and the Body 
 While some moderate alcohol intake has been linked to beneficial effects on human 
health, alcohol abuse can lead to an abundance of health consequences.  Alcohol has been shown 
to have both positive and negative effects on cardiovascular health.  Furthermore, alcohol use 
and abuse is implicated in diseases of the liver and pancreas, it has also been linked to the 
development of several types of cancer, and is known to suppress immune function.  Many 
studies have demonstrated that moderate alcohol intake is beneficial to cardiovascular health.  A 
recent meta-analysis of such studies found that moderate alcohol drinkers had reduced incidence 
of cardiovascular disease, coronary heart disease, and stroke (Ronksley, Brien, Turner, 
Mukamal, & Ghali, 2011).  Chronic alcohol abuse can have the opposite effect on the 
cardiovascular system.  Heavy alcohol use is associated with cardiomyopathies, arrhythmias, 
stroke, and hypertension (Piano & Schwertz, 1994).  Chronic alcohol use is also implicated in the 
development of liver disease including fatty liver disease, hepatitis, fibrosis, cirrhosis, and is 
linked to increased risk of liver cancer (Lee & Kowdley, 2012).  Alcohol use may also be a risk 
factor for pancreatitis and the subsequent risk for the development of pancreatic cancer 
(Tramacere et al., 2010).  Alcohol is also directly linked to the development of cancers of the 
mouth, pharynx, larynx, esophagus, colon, and rectum; and has been recently correlated with 
breast cancer in women (Boffetta & Hashibe, 2006).  Finally, acute and chronic use of alcohol 
can suppress the immune system via both the innate and adaptive immune response (Molina, 
Happel, Zhang, Kolls, & Nelson, 2010). 
Cyclic AMP signaling 
 Cell signaling is a means for communicating information about the environment between 
cells and propagating a response within individual cells to address the needs of the organism.  
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Most cell signaling cascades involve an extracellular first messenger, usually a hormone or 
neurotransmitter, which binds to a receptor located within the cell membrane.  Depending on the 
type of cell, binding of the first messenger (also known as ligand) to the receptor will initiate an 
intracellular signaling cascade.  Receptors can be ion channels, where binding of the ligand 
opens the ion channel leading to the influx or efflux of certain ions which change the electrical 
potential of the cell.  Receptors can also be linked to other proteins in the membrane where 
binding of the ligand initiates various intracellular events; many of the signaling cascades 
involve second messengers as well.  Cyclic adenosine monophosphate (cAMP) is a common 
second messenger and is involved in a diverse array of cellular functions. 
 cAMP is involved in many biological processes including learning and memory, 
glycolysis, fatty acid metabolism, myocardial contraction, oncogenesis, cytokine production, 
gene expression, and cell growth and survival to name a few.  cAMP signaling pathways consist 
of a GPCR linked to heterotrimeric G proteins (guanine nucleotide-binding regulatory proteins).  
Binding of a receptor ligand to the GPCR causes a conformational change in the receptor leading 
to interaction with the heterotrimeric G protein; this interaction causes the displacement of GDP 
by GTP.  The GTP-bound G protein is in the active state which causes the dissociation of the 
protein into the subunits α and βγ; both of these subunits are implicated in activating effector 
proteins and thus modifying second messenger levels within the cell (Figure 1.1) (Strader, Fong, 
Tota, Underwood, & Dixon, 1994).  The effector protein responsible for the production of cAMP 
is adenylyl cyclase (AC).   
 There are nine membrane-bound isoforms and one soluble isoform of mammalian AC.  
AC is found in many cell types in the body, various isoforms are expressed differentially among 
tissue type and organ systems (Sunahara & Taussig, 2002).  AC isoforms are classified based on 
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Figure 1.1.  Schematic representation of cAMP signaling cascade.  The binding of an 
extracellular ligand to the GPCR activates the G protein which activates AC.  AC converts ATP 
to cAMP.  cAMP has many effectors including protein kinase A (PKA).  Excess cAMP is 
degraded by phosphodiesterase (PDE). 
 
the variation in regulatory mechanisms; primary regulators of AC activity include G proteins, 
calcium, calmodulin, protein kinase C (PKC), and small molecules such as forskolin and 
magnesium (Sunahara & Taussig, 2002; Cooper, 2003).  The structure for membrane-bound AC 
consists of a cytoplasmic N-terminal domain (N), followed by a membrane-spanning domain 
(M1), a cytoplasmic domain (C1a and C1b), a second membrane-spanning domain (M2), and a 
second cytoplasmic domain (C2a and C2b) (Tesmer & Sprang, 1998).  Adenylyl cyclase catalyzes 
the reaction that converts ATP into cAMP.  The C1a and C2a domain are homologous and 
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constitute the catalytic core (Tesmer & Sprang, 1998).  The cytoplasmic domains are also where 
key regulators of AC interact with the protein, including G protein subunits as well as small 
molecule activators of AC such as magnesium and forskolin (Sunahara & Taussig, 2002).  The G 
protein subunits Gα and Gβγ have multiple isoforms which can stimulate or inhibit AC 
depending on the characteristics of the AC isoform.  Gαs always stimulates AC activity, Gαi is 
inhibitory to susceptible isoforms, Gαo is typically inhibitory to affected AC isoforms, and recent 
research implicates Gα12/13 as stimulatory to some AC isoforms, especially Type 7 AC isoform 
(AC7) (Sunahara & Taussig, 2002; Jiang, Collins, Davis, Fraser, & Sternweis, 2008).  The 
subunit Gβγ can either stimulate or inhibit AC activity depending on the AC isoform; 
furthermore, the effect of Gβγ often requires concurrent activation by Gα (Sunahara & Taussig, 
2002).  G protein subunits bind to the catalytic complex along the perimeter of the C1/C2 
interface; binding sites for the ATP substrate along with AC regulators such as magnesium and 
forskolin are located within the catalytic cleft (Sunahara & Taussig, 2002).   
Effect of Alcohol on cAMP Signaling 
 The cAMP signaling pathway has been implicated in the development of and 
predisposition to alcoholism.  Abnormalities in cAMP signaling and changes in the activity of 
adenylyl cyclase have been observed in clinical populations of alcoholics.  Furthermore, 
experimental models have been designed that implicate the cAMP signaling system in the 
response to alcohol and particularly establish adenylyl cyclase as a major contributor to the 
alcohol response. 
Clinical Evidence of Alcohol Effect on Adenylyl Cyclase 
Early clinical research established a link between cAMP signaling and alcoholism. 
Diamond and colleagues found that basal and stimulated levels of cAMP were lower in the 
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lymphocytes of alcoholics (Diamond, Wrubel, Estrin, & Gordon, 1987).  Lymphocytes were 
extracted from blood samples from alcoholic patients and age matched controls.  Mixed 
lymphocyte preparation and isolated T cells were assayed for cAMP accumulation alone or in the 
presence of an adenosine receptor agonist or 80mM ethanol.  The results indicated that basal, 
receptor-stimulated, and ethanol-stimulated cAMP levels were reduced significantly in both the 
mixed lymphocytes and isolated T cells from alcoholic patients (Diamond et al., 1987).  Further 
research demonstrated a reduction of ethanol-stimulated cAMP in cultured lymphocytes of 
alcoholic patients.  Again, lymphocytes were extracted from blood samples from alcoholics and 
controls; lymphocytes were propagated using cell culture for at least 4 generations of growth in 
medium not containing alcohol.  Despite the multiple rounds of cell division in the absence of 
alcohol, ethanol-stimulated cAMP levels were still suppressed in the lymphocytes of alcoholics 
when compared to controls (Nagy, Diamond, & Gordon, 1988).  Platelets from abstaining 
alcoholics and controls with family history positive or negative for alcoholism were analyzed for 
AC activity. Controls which were complete abstainers from alcohol but with a family history 
positive for alcoholism had lower basal and stimulated AC activity levels than complete 
abstainers with no family history of alcoholism, suggesting AC activity as a possible trait marker 
for genetic predisposition for the development of alcoholism (Menninger, Baron, & Tabakoff, 
1998).  Patients with a history of alcoholism had reduced stimulated AC activity in the platelets 
when compared to individuals with no history of alcoholism; these results were taken after the 
patient had abstained from alcohol for at least 4 days (Menninger et al., 2000), suggesting a 
biochemical marker for the diagnosis of alcohol dependence. 
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Experimental Evidence of Alcohol Effect on Adenylyl Cyclase 
 Alcohol has been shown to modulate cAMP signaling in experimental animal models.  
Several alcohol-related parameters have been associated with modulated cAMP signaling.  Initial 
sensitivity to ethanol, as measured by test of balance on a dowel, was shown to correlate with 
cAMP accumulation in the cerebellum and basal ganglia of mice (Kirstein & Tabakoff, 2001).  
Several studies have also been carried out which focus on the AC component of cAMP signaling 
in the alcohol response.  Double knock-out (DKO) mice lacking both AC1 and AC8 had 
increased sensitivity to alcohol-induced sedation, further, DKO mice and AC8 KO mice exhibit 
decreased voluntary ethanol consumption compared to wild type mice (Maas, Jr. et al., 2005).  
AC5 KO mice have also been examined for alcohol response.  AC5 KO mice show higher 
preference for ethanol as well as increased total consumption of ethanol compared to wild type 
mice (Kim, Kim, Baek, Lee, & Han, 2011).  Additionally, AC5 KO mice had reduced sensitivity 
to ethanol under the measures of ethanol-induced hypothermia and sedation by high-dose ethanol 
(Kim et al., 2011).  AC5 has also been implicated in the anxiolytic effects of alcohol and is 
highly expressed in the nucleus accumbens, a component of the reward center in the brain.  
Decreased AC5 mRNA expression was found in the nucleus accumbens of rats as early as 1 hour 
following ethanol treatment (Morales-Mulia et al., 2012).  Another study found that 
overexpression of AC7 in mice increased basal and ethanol-induced DARPP-32, a downstream 
element of the cAMP pathway implicated in motivation for ethanol intake (Donohue, Hoffman, 
& Tabakoff, 2005).   
 From a basic science viewpoint, our laboratory has focused on the interaction of adenylyl 
cyclase with alcohol.  Early research found an isoform specificity of the alcohol effect 
(Yoshimura & Tabakoff, 1995).  The following study found that receptor-stimulated cAMP 
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accumulation to be increased over 50% in response to treatment with 50mM ethanol in cells 
overexpressing AC7 (Yoshimura & Tabakoff, 1999).  Subsequent analysis identified the ethanol 
responsive domains of AC, i.e. the coding regions required for an ethanol effect to occur 
(Yoshimura, Pearson, Kadota, & Gonzalez, 2006). Full length chimeric mutants were designed 
from the sequences of AC2, AC3, and AC7.  This study showed that regions of the cytoplasmic 
domains, C1a and C2, were the only elements required for the alcohol effect; neither the 
membrane-spanning regions nor the N-terminal tail were necessary (Yoshimura et al., 2006).  
The work on isoform-specificity was extended by demonstrating that different AC isoforms have 
different responses to a series of n-alkanols (Kou & Yoshimura, 2007).  Alcohol cut-off point on 
the function of a protein is defined as the length of the carbon chain of an n-alkanol beyond 
which increasing the length of the carbon chain does not further increase alcohol effect on the 
protein.  AC6, AC7, and AC9 were found to have different alcohol cut-off points, which are 
proposed to be the result of specific alcohol binding pockets on the AC protein (Kou & 
Yoshimura, 2007).  Additional studies showed that these isoforms also responded differently to 
the number and position of hydroxyl groups in a straight chain alcohol (Hasanuzzaman & 
Yoshimura, 2010).  Using a FRET based cAMP sensor, cAMP was monitored in real-time and 
the results confirmed biochemical assays showing increased cAMP in the presence of alcohol, 
that the alcohol effect is isoform specific, and presented detailed time course of intracellular 
cAMP change (Gupta, Qualls-Creekmore, & Yoshimura, 2013). 
 Because this research was executed in mammalian cells, the role of AC is not definitive; 
endogenous ACs or other proteins may also contribute to the observations described.  Therefore, 
a recombinant AC protein was designed to contain the regions of AC previously identified as 
ethanol responsive domains.  This recombinant protein, AC7sol, was expressed in E. coli 
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containing no endogenous AC activity (Dokphrom, Qualls-Creekmore, & Yoshimura, 2011).  
This study found that the C1a and C2 domains of AC7 were sufficient to obtain the enhancing 
effect of alcohol and demonstrated that no other mammalian proteins are required for the alcohol 
enhancing effect on AC.  The alcohol cutoff point for AC7sol was determined to be pentanol, 
which is in agreement with the alcohol cutoff of the native AC7 expressed in mammalian cell 
culture (Kou & Yoshimura, 2007; Dokphrom et al., 2011).  Additionally, kinetic analysis of 
AC7sol found that ethanol increases both the Km and Vmax values associated with the enzymatic 
activity of AC7sol indicating that substrate turnover number and rate are increased in the 
presence of ethanol (Dokphrom et al., 2011).   
Statement of the Problem and Specific Aims 
In light of this most recent research, we have determined that the bacterial expression of 
recombinant AC is a very good model for investigating the specific interactions between alcohol 
and AC.  It is necessary to affirm that no other proteins are contributing to the alcohol effect on 
AC; this requires obtaining purified protein for further analysis.  Because native adenylyl cyclase 
is a membrane-bound protein, it is not feasible to express and purify the protein in full length 
form.  Previous research in our lab has narrowed down the interaction of alcohol and AC to the 
cytoplasmic domains.  Therefore, recombinant DNA design for the expression of soluble 
constructs of the AC cytoplasmic domains is sufficient for the study of alcohol’s effect on AC.   
Although the structures have been resolved for some segments of AC isoforms, the 
structure of AC7 has not been resolved.  Based on the resolved AC structures, the binding sites 
for catalytic substrates including ATP and magnesium, along with the binding sites for AC 
regulators such as G proteins and forskolin, are already established.  This knowledge permits us 
to interpret the mechanism of alcohol on AC through manipulation of the AC substrates and 
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regulators and subsequent kinetic analysis.  We can also manipulate the sequence of AC and 
combination of AC regions in order to further investigate the alcohol effect.  Identifying the 
specific AC regions required for the alcohol effect can help reveal a mechanism for how alcohol 
affects protein function and potentially open the door for future drug development.  We 
hypothesize that alcohol directly interacts with the adenylyl cyclase protein, leading to the 
observed alteration in cAMP accumulation.  Our objective is to determine the mechanism by 
which alcohol exerts its effect on adenylyl cyclase.  We have addressed these research problems 
with the following aims: 
Aim 1:  Design, express, and purify recombinant AC proteins for AC2, AC7, and AC9. 
Aim 2:  Characterize AC activity and isoform specificity for the effect of alcohol on AC. 
Aim 3:  Use pharmacological analysis to identify potential regulatory mechanism for 
alcohol on AC. 
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CHAPTER 2. 
DESIGN AND OPTIMIZATION OF CONDITIONS FOR THE 
EXPRESSION AND PURIFICATION OF RECOMBINANT MAMMALIAN 
ADENYLYL CYCLASE PROTEINS 
  
Introduction 
 One of the most significant challenges in protein research is the availability of sufficient 
quantities of the protein under investigation.  The development of recombinant DNA technology 
has broadened the possibilities within this field of research.  Researchers now have the capability 
to engineer DNA for encoding the RNA sequence of partial or complete proteins in the 
laboratory.  Various expression and purification systems can then be used to express and extract 
proteins for further use and analysis. 
  Methodologies for expressing recombinant protein include expression in mammalian 
cells, insect cells, yeast, bacterial cells, and even cell-free protein synthesis.  Each method has 
benefits and limitations; choice of expression system will depend upon the needs of the specific 
protein to be expressed (post-translational modifications), desired protein yield, and cost/time 
limitations.  In the current study, we chose the bacterial expression system for its ability to yield 
large amounts of protein, relatively fast production rate, and because our protein, adenylyl 
cyclase, does not require any post-translational modification for the purpose of our research.  
Furthermore, numerous strains of Escherichia coli (E. coli) have been engineered carrying 
plasmids with features specifically designed to control the process of protein expression and 
improve the final protein product. 
 Protein purification methods include the extraction of proteins from E. coli, separation of 
soluble and insoluble cell matter, followed by the separation of proteins based on a selected 
feature using chromatography.  Several methods of chromatography are available which separate 
proteins by characteristics such as size, hydrophobicity, or ionic charge.  In affinity 
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chromatography, a column is loaded with beads engineered to bind a specific compound.  The 
DNA plasmid encoding the target protein can also be designed to include a tag for the purpose of 
purification.  In immobilized metal affinity chromatography (IMAC), a sequence of multiple 
histidine residues is included at the N-terminal or C-terminal of the target protein sequence.  
Histidine binds to metal ions including cobalt and nickel, which can be attached to column beads 
for binding the histidine tag.  For elution of proteins, the columns are flushed with a solution that 
competes with the target protein for binding to the column; in the example of IMAC, imidazole, 
a chemical similar in structure to histidine, is added in increasing concentration to displace the 
bound histidine residues.    
 Optimization of protein expression and purification can occur at each stage of the 
process.  Selection of the plasmid for carrying the target protein coding sequence is the first 
crucial step.  Many plasmid features, including plasmid copy number and choice of RNA 
polymerase, can be manipulated to maximize protein expression.  Variables of cell culture can be 
modified such as E. coli strain, culture medium, incubation time, incubation temperature, 
incubator rotation speed, and concentration of induction reagent.  Cell lysis is the first step in 
protein purification and can be performed by physical means such as homogenization, 
sonication, or freeze-thaw cycling, or by chemical means such as a detergent-based solution.  
Again, determining the method for lysis depends on the specific needs of the protein; some 
methods may be too harsh and damage the functionality of the protein.  Many of the variables 
associated with protein purification involve maintaining the integrity of the protein, these include 
appropriate buffer selection, maintenance of an appropriate and consistent temperature 
throughout purification protocols, and the addition of protease inhibitors, chelators, reducing 
agents such as beta-mercaptoethanol and dithiothreitol (DTT), or glycerol to working buffers to 
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prevent protein degradation and improper protein folding.  Method of chromatography is also 
important for recovering maximum protein yield.  Chromatography selection or the use of 
sequential columns is important for protein yield and protein purity.  For some proteins, affinity 
chromatography may be sufficient.  Other proteins may require a second or third 
chromatography in addition to the affinity column, such as an ion exchange column or gel 
filtration column for achieving maximum protein purity. 
The adenylyl cyclase protein is a functional enzyme, and thus must not only maintain 
structural integrity, but functional integrity as well.  This remains the most significant challenge 
in the production of purified AC.  Because AC is a membrane-bound protein, it is difficult to 
express and purify the full sequence of the protein and must be done using insect or yeast cells.  
Therefore, research has focused on the cytoplasmic domains of AC, especially the regions 
responsible for catalytic activity.  Still, many attempts by researchers to express and purify the 
cytoplasmic (C1 and C2) regions of AC have resulted in low levels of expression and insolubility.  
From the nine membrane-bound AC isoforms, successful expression and purification has been 
reported for AC1 C1, AC2 C2, AC5 C1, AC5 C2, AC7 C1, AC7 C2, AC9 C1, and AC9 C2 (Tang & 
Gilman, 1991; Dessauer & Gilman, 1996; Yan, Huang, Rao, Hurley, & Tang, 1997; Zhang, Liu, 
Ruoho, & Hurley, 1997; Tesmer, Sunahara, Gilman, & Sprang, 1997; Tesmer, Sunahara, Fancy, 
Gilman, & Sprang, 2002; Scholich, Barbier, Mullenix, & Patel, 1997; Yan & Tang, 2002; Yan, 
Huang, Andrews, & Tang, 1998).   
In order to study the effects of alcohol on AC, our lab has generated recombinant protein 
constructs for multiple AC isoforms.  Research suggests that the cyclic AMP (cAMP) pathway is 
implicated in the development of and/or predisposition to alcoholism.  Previously, our laboratory 
has demonstrated that alcohol enhances the activity of AC, that the alcohol effect is isoform 
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specific, and that the isoform AC7 is most enhanced by alcohol.  We hypothesize that alcohol 
enhances AC activity by directly interacting with the protein.  Testing our hypothesis will be 
most definitive with the use of purified AC protein.  In order to achieve purified protein, we 
designed recombinant DNA plasmids encoding protein sequences for C1a and C2 regions of AC 
joined by an amino acid linker; AC2sol and AC7sol.  We also designed recombinant DNA 
plasmids for expressing the C1a and C2 regions separately for AC2, AC7, and AC9.  Here we 
present the results of optimization conditioning for both the expression and purification stages of 
recombinant AC protein production.   
Materials and Methods 
Materials 
Restriction enzymes were from New England Biolabs (Ipswich, MA).  Phusion Hot Start 
DNA polymerase and Quick Ligation Kit were from New England Biolabs (Ipswich, MA).  
Bacto Tryptone and Bacto Yeast were from BD (Franklin Lakes, NJ).  NiNTA superflow nickel 
chromatography cartridges were from Qiagen (Germantown, MD).  HisPur Cobalt 
chromatography cartridges were from Pierce Biotechnology (Rockford, IL).  HiTrap SP HP and 
HiTrap Q HP ion exchange chromatography cartridges were from GE Healthcare (Piscataway, 
NJ).  BCA protein assay kit was from Pierce Biotechnology (Rockford, IL).  His-Tag 
monoclonal antibody was from Novagen by EMD Millipore (Darmstadt, Germany).  Anti-mouse 
secondary antibody conjugated horseradish peroxidase was from Jackson ImmunoResearch 
Laboratories (West Grove, PA).  ECL western blotting detection reagents were from GE 
Healthcare (Piscataway, NJ).  Calbiochem Protease Inhibitor Cocktail II was from EMD 
Millipore (Darmstadt, Germany).  [
3H] cAMP was from Moravek Biochemicals (Brea, CA).  [α-
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32
P] ATP was from Perkin Elmer (Boston, MA).  All other chemicals and reagents used were 
from Sigma-Aldrich (St. Louis, MO). 
Construction of Recombinant AC 
Recombinant proteins were designed to include the ethanol responsive domains already 
identified in the native AC7 protein (Yoshimura, Pearson, Kadota, & Gonzalez, 2006).  AC2 and 
AC9 recombinants were designed to include the regions corresponding in sequence homology to 
the ethanol responsive domains of AC7 (Figure 2.1.).   
 
Figure 2.1.  Schematic representation of recombinant AC constructs.  The top figure represents 
the structure of the native form of AC7; ethanol responsive domains (ERD) have been indicated 
in red.  The numbers indicate the positions of the residues in the respective native isoform.  
6xHis indicates a hexahistidine tag.  
 
AC2sol and AC7sol included both C1a and C2 regions linked by a 14-amino acid linker; C1a and 
C2 were also expressed separately for isoforms AC2, AC7, and AC9.  The N-terminal tail, 
transmembrane-spanning domains, and C1b regions were excluded from the recombinant 
proteins.  All recombinant proteins included a hexahistidine tag for purification purposes.  DNA 
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fragments were amplified by polymerase chain reaction (PCR) from their respective template 
DNA (Table 2.1.), DNA polymerase, and two oligonucleotide primers (Table 2.2.).   
 
Table 2.1.  Gen Bank identification numbers for template DNA used in the design and 
construction of recombinant AC proteins. 
  
Template DNA Gen Bank Identification   
Rat AC2 M80550 
Human AC7 D25538 
Mouse AC9 MN009624 
 
 
Table 2.2.  Oligonucleotide primers used for the construction of recombinant AC proteins. 
  
Plasmid Primer 
AC2sol – C1a Forward: 5’ – ATCGGATCCACAAGCACCTCATGGAGCT 
Reverse: 5’ – GAACTCGAGGCTCCGTCCAGAGTGTGTC 
AC2sol – C2 Forward: 5’ – CACGAATTCTAGGAGCCTGAAAAATGAGG 
Reverse: 5’ – CAGAAGCTTCAGGATGCCAAGTTGCTCT 
AC2sol linker Forward: 5’ – TCGAGTGCAGCAGGAGGAGCAGCAGGAGGAGCAGCG 
Reverse: 5’ – AATTCGCTGCTCCTCCTGCTGCTCCTCCTGCTGCAC 
AC7sol – C1a Forward: 5’ – ATCGGATCCACAAGCACCAAATGCAGGA 
Reverse: 5’ – GAACTCGAGGCCGCGTCCCCCTTGGGCC 
AC7sol – C2 Forward: 5’ – ATCGGATCCGACAAGTTAAACGAGGACTG 
Reverse: 5’ – CAGAAGCTTCAGTTCAGCCCCAGCCCCTGAAA 
AC7sol linker Forward: 5’ – TCGAGTGCAGCAGGAGGAGCAGCAGGAGGAGCAGCG 
Reverse: 5’ – AATTCGCTGCTCCTCCTGCTGCTCCTCCTGCTGCAC 
AC2 C1a Forward: 5’ – ATCGGATCCACAAGCACCTCATGGAGCT 
Reverse: 5’ – GAAAAGCTTCAGGCTCCGTCCAGAGTGTGTC 
AC2 C2 Forward: 5’ – CCAGGATCCTCAGGAGCCTGAAAAATGAGGAGC 
Reverse: 5’ –CAGAAGCTTCAGGATGCCAAGTTGCTCT 
AC7 C1a Forward: 5’–ATCGGATCCACAAGCACCAAATGCAGGA 
Reverse: 5’ –GAAAAGCTTCAGGCCGCGTCCCCCTTGGGCC 
AC7 C2 Forward: 5’ – ATCGGATCCGACAAGTTAAACGAGGACTG 
Reverse: 5’ – CAGAAGCTTCAGTTCAGCCCCAGCCCCTGAAA 
AC9 C1a Forward: 5’ – ATGGGATCCATCTGTTTGTCATG 
Reverse: 5’ – CAGAAGCTTCAAAGGTTATCAAAGGTTTTGA 
AC9 C2 Forward: 5’ – ATCGGATCCAGCTCAAGGTCTCTCAGAC 
Reverse: 5’– CAGAAGCTTCACACACTCTTTGAGACAT 
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For separate C1a and C2 constructs, the resulting PCR product was digested with BamHI and 
HindIII and ligated into pQE82L or pET30c also digested by Bam HI and HindIII.  For AC2sol 
and AC7sol, the PCR product for the C1a domain was digested with BamHI and XhoI and ligated 
into pQE82L digested with the same enzymes.  The PCR product for the C2 domain was digested 
with EcoRI and HindIII and ligated into pQE82L containing the C1a coding sequence digested 
with the same enzymes.  The 14-amino acid linker was inserted into the plasmid containing the 
C1a and C2 coding sequences digested by XhoI and EcoRI.  Resulting plasmids included pET30c 
AC7C1a, pQE82L AC2sol, pQE82L AC7sol, pQE82L AC7 C1a, pQE82L AC7 C2, pQE82L AC2 
C1a, pQE82L AC2 C2, pQE82L AC9 C1a, and pQE82L AC9 C2 (Fig. 2.2.).  The coding sequence 
of each plasmid was confirmed by DNA sequencing analysis.   
 
Figure 2.2.  Diagram representing the design and features of the plasmid with vector pQE82L 
and AC7 C1a insert. 
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Expression of Recombinant AC 
Plasmids were transformed in an E. coli expression system using cell lines TP2000 
carrying plasmid pUSB520, Rosetta Gami B, BL21 (DE3) carrying plasmid pUSB520, or C41, 
and grown overnight on LB plates treated with appropriate antibiotics.  The next day, colonies 
were harvested and inoculated in LB, T7, or TB medium with antibiotics required for the 
plasmid and/or cell line and grown at various temperatures and rotational speeds until the A600 
reached 2.  This seed culture was then inoculated in 4L medium plus antibiotics and continued to 
grow at various temperatures and speeds.  Protein expression was induced at various A600 
values with variable concentrations of isopropyl β-D-1-thiogalactopyranoside (IPTG).  
Following IPTG induction, the culture was grown for multiple durations at various temperatures 
and speeds.  The culture was then harvested by centrifugation and cell pellets were stored at        
-80°C.   
Purification of Recombinant AC 
The purification procedure was carried out either on ice or at 4°C.  Cells were suspended 
in cold lysis buffer solution (20mM Tris pH 7.4, 5mM βmercaptoethanol, 100μM 
phenylmethylsulfonyl fluoride (PMSF), 22μg/ml N-p-tosyl-L-phenylalanine chloromethyl 
ketone (TPCK), 22μg/ml N-α-tosyl-L-lysine chloromethyl ketone hydrochloride (TLCK), trypsin 
inhibitor, and Sigma Protease Inhibitor Cocktail 1 tablet/100ml (4-(2-Aminoethyl) benzenesu
lfonyl fluoride hydrochloride (AEBSF), Bestatin hydrochloride, Leupeptin, E-64, Aprotinin, 
Pepstatin A, and Phosphoramidon disodium salt)  and lysed by sonification in the presence of 
lysozyme (1mg/ml) on ice.  Soluble proteins were separated by ultracentrifugation at 45,000rpm 
and loaded onto an immobilized metal affinity column (IMAC), washed with a Tris pH 7.4 
buffer containing 500mM NaCl, followed by the same buffer containing 100mM NaCl and 
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10mM Imidazole until A280 decreased to a plateau.  Proteins were eluted into 20 fractions using 
an imidazole gradient 10mM-500mM.  Eluted fractions were analyzed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fractions containing the target 
protein were pooled for subsequent purification by ion exchange chromatography.  The pooled 
fractions were diluted by 5 volumes in loading buffer (20mM Tris pH 7.4, 1mM DTT, 500μM 
ethylenediaminetetraacetic acid (EDTA), Calbiochem Protease Inhibitor Cocktail, and 100μM 
PMSF) and loaded to the HiTrap Q-HP or HiTrap SP-HP 5ml column depending on the charge 
of the target protein.  The column was washed with the loading buffer and proteins were eluted 
into 50 fractions using a NaCl gradient 0-1M.  Eluted fractions were again analyzed by SDS-
PAGE and fractions containing the target protein were pooled.  Pooled fractions were 
concentrated using Amicon Ultra 10K filters under centrifugation at 4°C, 4000rpm and stored at 
-80°C.      
Protein Analysis 
Purified proteins were separated by SDS-PAGE and stained with Bio-safe coomassie 
stain (BioRad).  SDS-PAGE results were also transferred to nitrocellulose membranes for 
western blot analysis.  Western-blotting used Anti-His monoclonal antibody to identify our 
proteins containing a 6 histidine tag at the N-terminus of the protein construct.  Briefly, 
membranes were blocked with 1% milk in tris-buffered saline (20mM Tris HCl pH 7.5, 150mM 
NaCl) with 0.2% tween 20 (TBST) for 1hr at room temperature.  Following washing, membranes 
were incubated with Anti-His antibody 1:1000 dilution overnight at 4°C.  Membranes were 
washed again and incubated with anti-mouse secondary antibody conjugated horseradish 
peroxidase, 1:5000 dilution.  Blots were developed using ECL chemiluminescent 
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immunodetection.  Finally, protein quantity was estimated using the BCA protein assay kit or 
based on their molecular extinction coefficient and A280. 
Enzymatic Activity Assay 
Our AC activity assay protocol uses [α-32P] ATP as a substrate.  The total reaction 
contains 10-15μg of total purified protein (ACsol or one C1a protein and one C2 protein 
combined), 250μM ATP, 25mM Tris-HCl pH 7.4, 100μM 3-isobutyl-1-methylxanthine (IBMX), 
10mM phosphocreatine, 5 U creatine phosphokinase, and [α-32P] ATP (50-80 cpm/pmol).  AC 
activity is stimulated with MnCl2.  Reaction mixtures are prepared on ice and the assay is 
initiated by temperature-shift to 30°C for 15min.  The reaction is terminated by the addition of a 
solution containing 2% SDS, 1mM ATP, and 1mM cAMP.  Sequential column chromatography 
is used to separate [α-32P] ATP and [α-32P] cAMP by dowex 50 and neutral alumina columns.  
3
H cAMP was added to estimate recovery of cAMP.  A liquid scintillation counter is used to 
detect radioactivity in the final sample (Salomon, Londos, & Rodbell, 1974).  All assays are 
carried out in triplicate and repeated for analysis of accuracy. 
Results 
AC2Sol & AC7sol 
AC2sol was expressed under manipulations of multiple conditions including cell line, 
culture medium, growth temperature, cell density at induction (A600), and IPTG induction 
concentration.  Cell lines included TP2000 pUSB520 and Rosetta Gami B; neither cell line 
produced a detectable improvement in protein expression or AC activity.  Culture mediums 
included T7 and TB; while T7 is standard use, TB includes more nutrients and is considered a 
richer growth medium.  However, change in culture medium did not improve protein expression.  
We tested two time and temperature conditions following the induction of protein expression 
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with IPTG; 6hr at 30°C and 19hr at 25°C.  No detectable difference in expression was found 
between conditions.  Finally, we varied conditions of protein induction including cell culture 
density (A600) at time of induction ranging from A600 value of 0.4 – 2 and IPTG concentration 
ranging from 100µM-1mM IPTG.  Again, no significant improvements resulted from any of 
these induction conditions.  Low protein expression and very low enzymatic activity did not 
encourage the purification of AC2sol and therefore further analysis of AC2sol was abandoned. 
Similar optimization of AC7sol was performed and optimal conditions were found to be 
the following: transformation in TP2000 pUSB520 cell line induction with 100µM IPTG when 
cell culture growth reached A600 value of 1 and continued growth of culture for 19hr at 25°C 
with shaking at 250rpm.  AC7sol expression and enzymatic activity was higher than AC2sol, 
therefore, we continued to protein purification.  AC7sol was purified using a Ni-NTA nickel 
affinity column eluted with imidazole, followed by an ion exchange column HiTrap SP-HP 
eluted with NaCl.  Initial purification of AC7sol did not result in the recovery of a large protein 
yield.  Therefore, in the subsequent purification, samples were collected from the pass through 
for each stage of purification including the unbound lysate sample and washes and analyzed by 
SDS-PAGE (Figure 2.3.) and enzymatic assay for AC activity (Table 2.3.).   
 
Table 2.3.  Estimated recovery of AC7sol during purification steps as measured by AC 
enzymatic activity assay.  
    
Purification Step Quantity (mg) Total Activity (pmol/min) % recovery 
Lysate 1012.7 85557 100 
Ni-NTA Unbound 962.2 77822 91 
Wash I 57.6 10380 12.1 
Wash II 10.8 395 0.46 
Ni-NTA Elution 0.7 33.50 0.04 
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Figure 2.3.  SDS-PAGE analysis of each stage in the purification process of AC7sol (60.9 kDa 
molecular weight). 
 
This data revealed that much of the active AC7sol was lost during the purification steps and not 
recovered in the final sample.  Attempting to improve the recovery of AC7sol during 
purification, we replaced the nickel affinity column with a cobalt affinity column.  Cobalt 
affinity chromatography did not result in greater recovery in the case of AC7sol.  Based on the 
difficulty encountered in the expression and purification of AC2sol and AC7sol and because the 
low level of enzymatic activity was not sufficient for study of the alcohol effect on AC, we 
decided to express and purify the C1a and C2 regions separately. 
 
 
    1            2          3           4          5          6           7            8 
          
1 – Lysate 
2 – Cobalt Unbound 
3 – Wash I 
4 – Wash II 
5 – Cobalt Elution 
6 – HiTrap Unbound 
7 – HiTrap Wash 
8 – Final Preparation 
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31 
 
AC7 C1a & AC7 C2                                                                                                                                                         
 Optimization of protein expression was first carried out for AC7 C1a.  One theory in the 
field of protein production is that “low and slow”, using low temperatures, and slow shaking 
speeds, and less rich culture medium such as LB, results in slower cell replication, and will yield 
the highest quality protein expression.  This theory is based upon the notion that slower growth 
will allow the bacterial machinery time to properly translate and fold the protein.  Our results did 
not find protein expression to be greater, however, we did notice a slight increase in the resulting 
enzymatic activity of the protein; suggesting that the protein may be more likely to fold correctly 
under the “low and slow” conditions maintaining a functional enzyme.  Optimal conditions for 
AC7 C1a expression were transformation in BL21 (DE3) competent cells, culture growth in T7 
medium with induction at A600 = 0.6 with 100µM IPTG and continued growing at 25°C, 
100rpm, for 19hr.  AC7 C2 was easy to express, conditions identified in the optimization of AC7 
C1a were used for AC7 C2 as well. 
Optimizing purification first required determining the best choice of column for 
chromatography.  We first determined that the cobalt affinity column recovered more of the 
target protein than the nickel affinity column.  Cobalt affinity resins were available in prepacked 
columns from several companies; we chose to compare columns from three companies including 
Pierce, Clontech, and Novagen.  Initial expression and purification procedures had determined 
that AC7 C2 consistently demonstrated high protein expression and high protein recovery during 
purification.  Therefore, we used AC7 C2 for comparison of cobalt column quality.  Surprisingly, 
columns from different manufacturers did affect both the recovery of protein as well as the 
elution profile for AC7 C2.  Based on the SDS-PAGE analysis of chromatography fractions from 
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each column (Figure 2.4.) we selected the HisPur cobalt affinity column by Pierce which was 
used for purification of all recombinant constructs thereafter. 
 
  A.           ←  Elution Fractions 1-20  → 
 
  B.           ←  Elution Fractions 1-20  → 
 
  C.           ←  Elution Fractions 1-20  → 
 
 
Figure 2.4.  Comparison of affinity chromatography cobalt columns Pierce (A), Novagen (B), 
and Clontech (C) by purification of AC7 C2 (25.6 kDa molecular weight), elution in 20 fractions. 
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Once we determined the most efficient chromatography column, we then focused on the 
quality of purified protein for each construct.  AC7 C2 eluted in a narrow peak with minor 
contamination by other proteins, however, we did observe some extent of protein precipitation.  
The addition of glycerol to the elution buffer was able to reduce protein precipitation of AC7 C2.  
The elution profile for AC7 C1a showed a wider peak and more contamination by other proteins.  
We assumed that the lower expression of AC7 C1a could be contributing to the contamination 
because the lower quantity of AC7 C1a binding to the column allowed for more non-specific 
binding of non-target proteins leading to the contamination in the final sample.   
Although we had already established an optimal method for the expression of AC7 C1a in 
our current vector system, pQE82L, we constructed a new plasmid by inserting the AC7 C1a into 
vector pET30.  The pET vector expression system is known for high levels of target protein 
expression and tight control over basal protein expression; however, the high expression levels 
can also increase protein precipitation and the pET vector includes a larger histidine tag that may 
interfere with enzymatic analysis.  Our results indicated that pET may slightly increase the 
expression of AC7 C1a; however, there is also more contamination.  Furthermore, analysis of 
enzymatic activity found slightly higher enzymatic activity but the alcohol effect on AC7 
disappeared (Figure 2.5.); confirming our fear that the use of the pET vector could interfere with 
enzymatic analysis. 
AC2 C1a, AC2 C2, AC9 C1a, & AC9 C2 
Expression and purification of AC2 C1a, AC2 C2, AC9 C1a, & AC9 C2 was carried out 
using the same methods outlined for AC7 C1a.  Despite multiple efforts, expression of AC2 C1a 
never resulted in a detectable amount of protein by western blot analysis or enzymatic assay.  
Expression of AC2 C2 and AC9 C2 followed a similar pattern as AC7 C2 with high levels of 
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Figure 2.5.  Enzymatic assay for comparison of AC7 C1a in pET30 paired with pQE82L AC7 
C2.  Enzymatic activity stimulated with 2.5mM MnCl2 in the presence and absence of 200mM 
ethanol.  
 
expression and only minor contamination following purification.  AC9 C1a followed a similar 
pattern as AC7 C1a with modest expression, though slightly higher than AC7 C1a, and 
purification resulting in a wide peak in the elution profile with more non-specific protein 
contamination.  Figure 2.6. shows the final quality of purified AC7 C1a, AC7 C2, AC2 C2, AC9 
C1a, & AC9 C2 as demonstrated by SDS-PAGE analysis. 
Discussion 
 AC2sol and AC7sol are considered large proteins (~60 kDa) relative to the bacterial 
expression system.  Expression of these constructs may have been stretching the capability of the 
system.  In the bacterial expression system, the larger proteins result in less successful 
expression.  AC2sol and AC7sol are both over 50kDa molecular weight.  Similar to our AC2sol 
and AC7sol, other researchers have expressed C1 and C2 regions in one intact recombinant 
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Figure 2.6.  SDS-PAGE analysis of purified recombinant AC constructs. 
 
protein by linking the two regions with an artificial amino acid sequence (Tesmer et al., 1997; 
Scholich et al., 1999).  However, these studies used isoforms AC5 and a chimera, AC5 C1+AC2 
C2. The isoform AC7 in purified form has only been studied by expressing and purifying the C1 
and C2 regions separately (Yan & Tang, 2002).  The sequence of AC2 is highly homologous to 
the sequence of AC7 and this could be one reason why we have had more difficulty with the 
expression of these isoforms compared to other research with AC1 and AC5.  While AC2 C2 was 
included in a recombinant chimera of AC1 C1 + AC2 C2 (Yan, Hahn, Huang, & Tang, 1996), our 
own data demonstrates the robust quality of AC2 C2, therefore our limiting factor is most likely 
AC2 C1a.  Although our intention with ACsol was to create one soluble intact construct for the 
isoforms under investigation, the designed proteins did not exhibit the expression or enzymatic 
activity necessary for further study of the alcohol effect on AC.  Fortunately, with the exception 
1 - AC7 C1a (33.7 kDa) 
2 - AC7 C2 (25.6 kDa) 
3 - AC2 C2 (26 kDa) 
4 - AC9 C1a (37 kDa) 
5 - AC9 C2 (35 kDa)   
      1                    2                  3         4      5 
MW  
(kDa) 
55 –  
35 –  
 
25 –  
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of AC2 C1a, the expression of the C1a and C2 regions separately resulted in proteins with 
sufficient expression and activity, allowing us to examine the alcohol effect on the purified 
proteins. 
Recombinant AC7 C1a and AC7 C2 have been separately expressed and purified by other 
researchers in the past.  Following separate protein production, investigators found that these 
proteins could be recombined and form an enzymatically active protein complex (Yan & Tang, 
2002).  We used the protocols established by this group as a guide for our own expression and 
purification of AC7 C1a and AC7 C2.  However, when designing our recombinant AC7 proteins, 
we needed to include the regions previously identified as ethanol responsive domains 
(Yoshimura, 2006).  The coding sequence for AC7 C2 used by Yan and Tang included the 
sequence noted as ethanol responsive domain 2; therefore we included the same sequence for our 
own AC7 C2 construct.  Our AC7 C1a construct needed to include two ethanol responsive 
domains, requiring us to code for amino acid sequence 197-475, encompassing the entire N-
terminal end of the AC7 C1a region, resulting in a larger AC7 C1a than had been expressed by the 
earlier group.  The larger size of AC7 C1a could be the cause of our difficulty with the expression 
levels and purification quality of AC7 C1a, however, this was unavoidable considering our 
knowledge of the ethanol responsive domains.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
We had high hopes for the expression of AC7 C1a in the pET vector.  While the protein 
was active, improvement of expression and purity was minor and we were not able to detect the 
effect of alcohol on enzymatic activity.  As mentioned, the histidine tag was much larger with the 
pET vector and could have interfered with the conformation of AC7 C1a or blocked the site of 
alcohol interaction.  Removal of the histidine tag from proteins expressed by the pET vector is 
possible because the tag sequence encoded by pET30 vector carries an enterokinase cleavage 
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site.  The enterokinase cleavage reaction requires incubation at room temperature or higher for at 
least 16 hours.  Following the enterokinase cleavage, the recombinant protein must be isolated 
from the excised histidine tag to achieve a pure protein sample.  This requires an additional pass 
through his-tag affinity resin.  All of these additional steps greatly increase the exposure of the 
recombinant protein to fluctuations in temperature and buffer conditions, and increase the 
probability for protein precipitation and degradation of catalytic integrity of the enzyme.  
Considering the already fragile state of our AC7 C1a recombinant, any benefits of the pET vector 
would be overshadowed by the added exposure of his-tag removal. 
All of our C2 constructs express and purify much cleaner than C1a.  While our C1a 
constructs are somewhat larger in molecular weight (C1a = ~35kDa & C2 = ~26kDa), this is likely 
not the only factor leading to the resulting differences in expression and purity.  One possibility 
is that the protein folding of C1a is more complex resulting in more difficulty during expression.  
The folding of the protein could also affect purification results if the conformation of the protein 
is folded in a way that may obstruct the his-tag making it less likely to bind the cobalt resin 
during purification.  While we acknowledge that our various AC C1a preparations are not 
completely homogenous, we will demonstrate in chapter 3 that our recombinant proteins retain 
enzymatic activity and demonstrate a response to alcohol similar to which we have observed in 
mammalian cell culture studies and in bacterial lysate preparations.  
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CHAPTER 3. 
CHARACTERIZATION OF THE EFFECT OF ALCOHOL ON 
RECOMBINANT ADENYLYL CYCLASE 
 
Introduction 
 Many biological processes are implicated in the development of alcoholism and the 
behavioral response to alcohol. Both human and model animal studies have implicated the cAMP 
signaling system in the development of and predisposition to alcoholism.  Specifically, many of 
these studies have implicated adenylyl cyclase as a crucial component of the ethanol effect on 
cAMP signaling. 
Enzymatic activity of AC in the platelets of alcoholics was shown to be reduced in 
patients after abstaining from alcohol for 4 days, and individuals who had consumed alcohol in 
the 3-4 days prior to platelet extraction, regardless of alcoholism history, showed higher basal 
and stimulated AC activity (Menninger et al., 2000).  Furthermore, complete abstainers from 
alcohol but with a family history positive for alcoholism had lower basal and stimulated AC 
activity levels than complete abstainers with no family history of alcoholism (Menninger, Baron, 
& Tabakoff, 1998), suggesting AC activity as a possible trait marker for genetic predisposition 
for the development of alcoholism.  Animal models of alcoholism have also explored the role of 
the cAMP signaling system.  Double knock-out (DKO) mice lacking both AC1 and AC8 had 
increased sensitivity to alcohol-induced sedation, further, DKO mice and AC8 KO mice exhibit 
decreased voluntary ethanol consumption compared to wild type mice (Maas, Jr. et al., 2005).  
AC5 KO mice show higher preference for ethanol as well as increased total consumption of 
ethanol compared to wild type mice (Kim, Kim, Baek, Lee, & Han, 2011).  Another transgenic 
study found that overexpression of AC7 in mice increased basal and ethanol-induced DARPP-
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32, a downstream element of the cAMP pathway implicated in motivation for ethanol intake 
(Donohue, Hoffman, & Tabakoff, 2005). 
Our laboratory has demonstrated that alcohol enhances the activity of AC in an isoform 
specific manner and that the isoform AC7 is most enhanced by ethanol as measured by cAMP 
accumulation assay in intact mammalian cells (Yoshimura & Tabakoff, 1995). Additionally, 
ethanol responsive domains of AC7 were shown to be localized in the cytoplasmic regions of the 
protein (Yoshimura, Pearson, Kadota, & Gonzalez, 2006).   Our lab found that different AC 
isoforms have different responses to a series of n-alkanols; AC6, AC7, and AC9 were found to 
have different alcohol cut-off points (Kou & Yoshimura, 2007).  We also generated a 
recombinant AC7 protein consisting of the C1a and C2 regions linked together which included the 
ethanol responsive domains.  This protein, named AC7sol, was expressed in a strain of E. coli 
lacking AC activity and lysate preparation was assayed for enzymatic activity devoid of any 
other mammalian proteins.  We found that AC activity was enhanced by alcohols in a manner 
consistent with our previous mammalian studies and demonstrated that the C1a and C2 regions are 
sufficient to produce the alcohol effect (Dokphrom, Qualls-Creekmore, & Yoshimura, 2011). 
In order to demonstrate that only the C1a and C2 regions are necessary for the alcohol 
effect, we used purified recombinant AC proteins to determine the effect of alcohol on AC in the 
absence of any other proteins.  Here we will confirm that our purified recombinant AC proteins 
for isoforms AC2, AC7, and AC9 are enzymatically functional through assays to characterize the 
response of our proteins to known AC stimulators.  Furthermore, we will confirm isoform 
specificity of the alcohol effect and perform chimeric analysis by combining C1a and C2 regions 
from different isoforms in order to test the importance of each region to the alcohol effect. 
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Materials and Methods 
Materials 
Bacto Tryptone and Bacto Yeast were from BD (Franklin Lakes, NJ).  NiNTA superflow 
nickel chromatography cartridges were from Qiagen (Germantown, MD).  HisPur Cobalt 
chromatography cartridges were from Pierce Biotechnology (Rockford, IL).  HiTrap SP HP and 
HiTrap Q HP ion exchange chromatography cartridges were from GE Healthcare (Piscataway, 
NJ).  BCA protein assay kit was from Pierce Biotechnology (Rockford, IL).  His-Tag 
monoclonal antibody was from Novagen by EMD Millipore (Darmstadt, Germany).  Anti-mouse 
secondary antibody conjugated horseradish peroxidase was from Jackson ImmunoResearch 
Laboratories (West Grove, PA).  ECL chemiluminescent immunodetection was from GE 
Healthcare (Piscataway, NJ).  Calbiochem Protease Inhibitor Cocktail II was from EMD 
Millipore (Darmstadt, Germany).  [
3H] cAMP was from Moravek Biochemicals (Brea, CA).  [α-
32
P] ATP was from Perkin Elmer (Boston, MA).  All other chemicals and reagents used were 
from Sigma-Aldrich (St. Louis, MO). 
Recombinant AC Production 
 Protein production is described in detail in Chapter 2.  Briefly, recombinant protein genes 
including hexahistidine tag for AC2 C2, AC7 C1a, AC7 C2, AC9 C1a, and AC9 C2 were 
constructed and inserted in vector pQE82L.  Resulting plasmids were transformed in E. coli cell 
line BL21 (DE3) and protein expression was induced with IPTG.  Cells were harvested by 
centrifugation, lysed by sonication, and the soluble protein fraction (lysate) was separated by 
ultracentrifugation.  The lysate preparation was loaded onto a cobalt metal affinity column, 
HisPur, washed to remove contaminants, and eluted in 20 fractions with an imidazole 
concentration gradient.  Fractions containing the target protein were pooled, and loaded onto an 
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ion exchange column, HiTrap Q-HP or HiTrap SP-HP, depending on the isoelectric point for 
each individual protein, washed to remove contaminants, and eluted in 50 fractions with a NaCl 
gradient.  Finally, fractions containing the target proteins were pooled and concentrated using an 
Amicon Ultra 10K filter by centrifugation at 4ºC, 4000rpm.  Protein quantity was measured by 
BCA protein assay kit or based on their molecular extinction coefficient and A280. 
Enzymatic Activity Assay 
Our AC activity assay protocol used [α-32P] ATP as a substrate.  The total reaction 
contained 10-15μg of total purified protein (one C1a protein and one C2 protein combined), 
250μM ATP, 25mM Tris-HCl pH 7.4, 100μM IBMX, 10mM phosphocreatine, 5 U creatine 
phosphokinase, and [α-32P] ATP (50-80 cpm/pmol).  AC activity was stimulated with MnCl2.  
Reaction mixtures were prepared on ice and the assay was initiated by temperature-shift to 30°C 
for 15min.  The reaction was terminated by the addition of a solution containing 2% SDS, 1mM 
ATP, and 1mM cAMP.  
3
H cAMP was added as an internal control to estimate the recovery of 
cAMP.  Sequential column chromatography by dowex 50 and neutral alumina columns was used 
to separate ATP and cAMP.  A liquid scintillation counter was used to detect radioactivity in the 
final sample (Salomon, Londos, & Rodbell, 1974).   
Data Analysis 
 All assay data were acquired in triplicate and each experiment performed at least twice to 
ensure reliability of measures.  Statistical analysis was carried out by t-test.  Sigma Plot and 
Sigma Stat (Systat Software, Point Richmond, CA) were used to plot and analyze data. 
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Results 
Enzymatic Activity of Recombinant AC 
 Before investigating the effect of alcohol on recombinant AC, it was first necessary to 
establish that our protein constructs form catalytically active complexes in vitro.  We performed 
the enzymatic activity assay for preparations of AC7 C1a alone, AC7 C2 alone, and AC7 C1a and 
AC7 C2 combined.  For each preparation, AC activity was stimulated with 2.5mM MnCl2.  We 
found that when assayed alone, C1a or C2 had activity levels not significantly different from 
background.  However, the combined preparation of C1a and C2 showed high levels of AC 
activity (Figure 3.1.).   These results demonstrated that even though the catalytic components, 
C1a and C2, are expressed and purified separately, they can be combined in vitro and enzymatic 
activity is restored. 
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Figure 3.1.  AC activity of recombinant AC7 C1a and AC7 C2 alone, and AC7 C1a + AC7 C2 
combined preparation.  AC activity is stimulated by 2.5mM MnCl2. 
  
 In our previous study using recombinant protein AC7sol, enzymatic activity assay was 
performed on AC7sol in a bacterial lysate preparation.  It was necessary to include an ATP 
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regeneration mechanism in our assay system to regenerate any ATP decomposed by potential 
ATPase in the crude protein sample.  Phosphocreatine and creatine kinase were used to 
regenerate ATP.  In the current study, we assumed the use of the ATP regeneration system would 
be unnecessary due to the purity of our protein samples.  We tested this assumption by assaying 
the combined preparation of AC7 C1a and AC7 C2 in the presence or absence of the ATP 
regeneration system.  As predicted, the ATP regeneration system was not necessary for our 
purified proteins; in fact, AC activity was actually suppressed by the use of the ATP regeneration 
system (Figure 3.2.).  
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Figure 3.2. AC7 C1a + AC7 C2 activity in the presence or absence of ATP regeneration system.  
AC activity stimulated by 2.5mM MnCl2.  
 
Isoform Specific Alcohol Effect 
We first examined the effect of alcohol on isoforms AC7 and AC9 homologous 
combinations.  Previous work in our lab established that the isoform AC7 is most responsive to 
ethanol while AC9 has a very weak response to ethanol.  AC7 C1a + AC7 C2 and AC9 C1a + AC9 
C2 combinations were assayed using manganese plus or minus 200mM ethanol.  As a control, 
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basal enzymatic activity was also measured.  No significant basal activity was observed for 
either AC7 or AC9 with or without ethanol (Figure 3.3.).  Both protein combinations were active 
when stimulated by MnCl2 alone (Figure 3.3.).  We examined the condition of MnCl2 + forskolin 
because AC9 is known to be less responsive to forskolin.  However, in this experiment, there 
was no significant difference between AC activity under conditions of MnCl2 alone or MnCl2 + 
forskolin for either AC7 or AC9.  In the presence of ethanol, we observed a significant 
enhancement of AC activity for the AC7 combination (Figure 3.3.A), while the AC9 
combination was significantly inhibited by ethanol (Figure 3.3.B).  These results are consistent 
with previous work in our lab indicating that the alcohol effect is isoform specific and AC7 is the 
most enhanced by alcohol. 
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Figure 3.3.  Basal AC activity, 2.5mM MnCl2 stimulated activity, and 2.5mM MnCl2 + 10 μM 
forskolin stimulated activity in the absence or presence of 200mM ethanol for AC7 C1a + AC7 
C2 (A) and AC9 C1a + AC9C2 (B).  * p < 0.05, *** p < 0.001 
 
Alcohol Effect on AC Chimeras 
In order to determine if one of the cytoplasmic domains has a dominant role in the 
ethanol effect on enzyme activity, we combined cytoplasmic regions from different AC isoforms.  
These chimeras included AC7 C1a + AC2 C2, AC7 C1a +AC9 C2, AC9 C1a + AC2 C2, and AC9 
A. B. 
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C1a + AC7 C2.  First we needed to ensure that the chimeric protein combinations maintained 
catalytic activity.  All of the chimeras were active, however, the specific activity for each of 
these chimeras varied (Figure 3.4.).  Furthermore, most of the chimeras were responsive to 
200mM ethanol.  Permutations containing AC7 C1a were enhanced by ethanol; permutations not 
containing AC7 C1a were inhibited by ethanol or showed no effect (Figure 3.5.).  This data would 
suggest that AC7 C1a plays a more vital role in the alcohol effect than does AC7 C2. 
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Figure 3.4.  AC activity for chimeric recombinant proteins.  AC activity stimulated with 2.5mM 
MnCl2. 
 
 
Discussion 
 To establish a direct effect of alcohol on adenylyl cyclase and that the alcohol effect has 
isoform specificity, we designed, expressed, and purified recombinant proteins for AC7, AC2, 
and AC9.  Cytoplasmic domains for each of these isoforms were expressed and purified 
separately.  Each of these recombinant proteins yielded acceptable levels of protein expression 
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Figure 3.5.  Effect of ethanol on MnCl2 stimulated AC activity in AC recombinant chimeras.  
*** p < 0.001.  Blue brackets represent the result of t-test in alcohol effect between chimeric 
conditions. 
 
and purification resulted in a highly pure protein product, with the exception of AC2 C1a.  The 
recombinant proteins were enzymatically active in both homologous and chimeric combinations 
of C1a and C2 domains.   
Consistent with our studies of the native AC protein expressed in a mammalian cell 
culture model system, the alcohol effect on AC appears to be isoform specific.  Also through our 
mammalian cell culture system, we found that AC9 is weakly stimulated by alcohols, but has a 
much different alcohol cutoff than AC7.  This is why we chose AC9 to investigate the isoform 
specificity of the alcohol effect.  We chose to include AC2 in the chimera study because among 
all of the AC isoforms, AC2 shares the most sequence homology with AC7 and both proteins are 
similarly regulated by components of the cAMP signaling cascade.  The response of purified 
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AC9 to alcohol was somewhat different than the alcohol response observed in native AC9 
expressed in mammalian cell culture.  When exposed to 200mM ethanol, the full length native 
AC9 expressed in HEK293 cells showed ~ 20% increase in activity; comparatively, under the 
same conditions AC7 showed ~40% increase in activity (Kou & Yoshimura, 2007).  The effect 
of alcohol on purified recombinant AC9 is an inhibition of enzymatic activity.  It is not 
unreasonable to find that the purified recombinants respond somewhat different than the native 
proteins for a number of reasons.  Because the purified proteins are assayed in vitro, the activity 
of AC must be stimulated differently than in the mammalian cell culture system; mammalian 
cells are stimulated through the activation of GPCRs, while the pure proteins are activated by 
small molecules that can bind within the catalytic cleft such as manganese or forskolin.  
Furthermore, in absence of the membrane-spanning domains, there is a potential for differences 
in protein conformation that may affect AC activity.  These results do not weaken our 
conclusions because our recombinant protein system still maintains the ability to produce an 
alcohol effect in an isoform specific manner.   
Previous research has shown that recombinant proteins representing the cytoplasmic 
domains from different AC isoforms can join together to form an active catalytic complex 
(Whisnant, Gilman, & Dessauer, 1996; Yan, Hahn, Huang, & Tang, 1996).  In fact, this is the 
manner by which much of the structural research on AC has been carried out.  Therefore, we 
decided to combine different AC cytoplasmic domains in order to test the importance of the C1a 
versus C2 domain to the observed isoform specific effect of alcohol on AC.  All of our chimeras 
had enzymatic activity when stimulated with manganese.  The activity of the chimera AC9 C1a + 
AC2 C2 had the lowest activity, but is still significantly higher in activity than the control 
reactions containing no protein. 
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Each AC chimera responded differently in the presence of 200mM ethanol.  The AC 
activity of chimeras containing AC7 C1a was enhanced by ethanol.  The AC activity of chimeras 
containing AC9 C1a was inhibited by ethanol.  Based on chimeric mutational studies carried out 
in the native AC structures, we expected that both cytoplasmic domains were necessary for the 
alcohol effect.  The study used components of isoforms AC2, AC3, and AC7 to create chimeras 
through exchange of all of partial sequences for all regions of the native AC, N-terminal tail, two 
membrane-spanning domains, and two cytoplasmic domains.  Following analysis of 30 chimeric 
mutants, ethanol responsive domains (ERD) were identified as the N-terminal 28 amino acid 
sequence of AC7 C1a and the C-terminal 140 amino acid sequence of AC7 C2 (Yoshimura, 
2006).  Our lab also found a third ERD, a short amino acid sequence located in the middle of the 
AC7 C1a region (unpublished data).  Our data supports the existence of ERDs in the AC7 C1a 
region but the contribution of ERD2 in AC7 C2 may be small since without AC7 C1a the alcohol 
effect is lost.   However, our data for AC7 C2 chimeras is somewhat limited.  Because we were 
not able to successfully express AC2 C1a, we only have one chimera including AC7 C2, AC9 C1a 
+ AC7 C2.  This limits any conclusions we might be able to formulate regarding ERD2. 
In conclusion, we have generated a series of recombinant AC proteins for the cytoplasmic 
regions of AC2 (C2), AC7, and AC9.  Although C1a and C2 regions are expressed separately, 
when joined together in homomeric or chimeric permutations, these constructs are enzymatically 
active and respond to ethanol.  We have confirmed that the alcohol effect is isoform specific and 
that AC7 is more enhanced by ethanol.  Finally, we have indicated the importance of AC7 C1a 
for the effect of alcohol on AC. 
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CHAPTER 4. 
ANALYSIS OF THE EFFECT OF ALCOHOL ON ADENYLYL CYCLASE: 
ALCOHOL CUTOFF AND ENZYME KINETICS 
 
Introduction 
 Adenylyl cyclase (AC) has been identified as a potential target for the effect of alcohol 
on cellular function.  As reviewed in Chapter 3, initial research established an effect of alcohol 
on the cAMP signaling system.  Studies in clinical populations of alcohol users as well as 
experimental laboratory models demonstrated changes to cAMP signaling during acute and 
chronic alcohol exposure.  There was also evidence that within the cAMP signaling cascade, it 
was the activity of adenylyl cyclase that was modified by alcohol exposure.  The primary 
objective in our laboratory has been to define the mechanism by which alcohol affects AC.  In 
review, through in vivo experimentation in a mammalian cell culture system our laboratory has 
demonstrated that alcohol enhances the activity of AC in an isoform specific manner with AC7 
most enhanced by ethanol (Yoshimura & Tabakoff, 1995; Yoshimura & Tabakoff, 1999).  
Furthermore, ethanol responsive domains of AC7 are in the cytoplasmic regions of AC 
(Yoshimura, Pearson, Kadota, & Gonzalez, 2006), alcohol cutoff points are isoform specific 
(Kou & Yoshimura, 2007), and AC response to alcohol stereoisomers is isoform specific 
(Hasanuzzaman & Yoshimura, 2010).  Additionally, the design and production of recombinant 
proteins for several AC isoforms allowed us to demonstrate that the effect of alcohol on AC 
persists in the absence of any other mammalian proteins while confirming the findings from the 
mammalian cell culture system indicating that the alcohol effect is specific to the cytoplasmic 
regions and that the alcohol effect is isoform specific (Dokphrom, Qualls-Creekmore, & 
Yoshimura, 2011). 
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 The first recombinant AC protein designed in our lab was AC7sol, which carried the C1a 
and C2 domains designed to include the ethanol responsive domains previously identified 
(Yoshimura, Pearson, Kadota, & Gonzalez, 2006).   AC7sol was expressed in E. coli, cells were 
lysed by sonication, crude bacterial lysate were prepared by ultracentrifugation, and AC activity 
analysis was carried out on the crude bacterial lysate.  Given that AC7sol is outside of the 
constraints of the cell membrane, we were able to examine the effects of several AC stimulators 
and multiple n-alkanols, and to perform kinetic analysis.  AC7sol retains the ethanol response 
and alcohol cutoff of native AC7 observed in intact cells (Yoshimura & Tabakoff, 1995; Kou & 
Yoshimura, 2007).  Furthermore, ethanol and butanol increased both Vmax and Km values for 
AC7sol indicating that ethanol increases the turnover rate for enzymatic activity of AC 
(Dokphrom et al., 2011).  Although AC7sol was expressed in TP2000, an E. coli strain which 
has no endogenous AC activity, because these experiments are carried out with crude bacterial 
lysate, we could not definitively conclude that the alcohol effect on AC does not involve 
additional proteins.  Purification of recombinant ACs was necessary to further research the 
alcohol effect on AC.  As presented in Chapter 3, purified recombinant proteins for AC2, AC7, 
and AC9 were enzymatically active and demonstrated isoform specific responses to alcohol.  
Further experiments were warranted to determine if the purified AC7 C1a and AC7 C2 
combination responded similarly to recombinant AC7sol and the native AC7 expressed in 
mammalian cells.  However, the alcohol effect observed in the analysis of our AC recombinant 
proteins was less dramatic than the alcohol effect seen on the native protein in mammalian cells 
or on AC7sol.  Because longer chain alcohols have more potent effects on AC, we decided to use 
longer chain alcohols such as butanol in further experiments on purified recombinant AC7. 
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Here were present data to demonstrate the effect of AC stimulators manganese, forskolin, 
and purified Gsα protein on AC7 C1a + AC7 C2.  During the first experiment we found that the 
use of all three of these AC stimulators synergistically increased the activity of AC.  
Furthermore, under this condition as well as conditions that included Gsα, the effect of alcohol 
on AC activity was inhibition rather than enhancement.  Somewhat similar observations were 
made for AC7sol when stimulated with Gsα, however, this is the first time to our knowledge that 
recombinant AC has been assayed in the presence of all three of these AC stimulators.  As a test 
of the validity of this unexpected inhibition, we designed an experiment to test if the inhibition of 
AC activity by alcohol when activated by manganese, forskolin, and Gsα followed the same 
alcohol cutoff point observed in the native AC7 and the recombinant AC7sol.  Alcohol cutoff is 
the point at which increasing the chain length of alcohol does not further increase the potency of 
the alcohol effect on AC.  Furthermore, based on these unexpected results, we determined that 
we could conduct concentration response analysis of AC7 C1a + AC7 C2 through the 
manipulation of concentration of AC stimulators and alcohols.  We expected that this analysis 
might further elucidate the mechanism of alcohol action on AC.   
Materials and Methods 
Materials 
Bacto Tryptone and Bacto Yeast were from BD (Franklin Lakes, NJ).  HisPur Cobalt 
chromatography cartridges were from Pierce Biotechnology (Rockford, IL).  HiTrap SP HP and 
HiTrap Q HP ion exchange chromatography cartridges were from GE Healthcare (Piscataway, 
NJ).  BCA protein assay kit was from Pierce Biotechnology (Rockford, IL).  His-Tag 
monoclonal antibody was from Novagen by EMD Millipore (Darmstadt, Germany).  ECL 
chemiluminescent immunodetection was from GE Healthcare (Piscataway, NJ).  Calbiochem 
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Protease Inhibitor Cocktail II was from EMD Millipore (Darmstadt, Germany).  [
3
H] cAMP was 
from Moravek Biochemicals (Brea, CA).  [α-32P] ATP was from Perkin Elmer (Boston, MA).  
Gsα was produced using plasmid pQE60 Gsα including a hexahistidine tag, expressed in E. coli 
cell line BL21 (DE3) containing pUBS520, and purified by affinity chromatography using the 
HisPur cobalt column and HiTrap Q HP ion exchange chromatography cartridge (Yan & Tang, 
2002).  Forskolin analogue NKH477 was from Tocris, R&D systems (Minneapolis, MN).  All 
other chemicals and reagents used were from Sigma-Aldrich (St. Louis, MO).   
Recombinant AC Production 
Protein production is described in detail in Chapter 2.  Briefly, recombinant protein genes 
including hexahistidine tag for AC7 C1a and AC7 C2 were constructed and inserted in vector 
pQE82L.  Resulting plasmids were transformed in E. coli cell line BL21 (DE3) containing 
pUBS520 and protein expression was induced with IPTG.  Cells were harvested by 
centrifugation, lysed by sonication, and the soluble protein fraction (lysate) was separated by 
ultracentrifugation.  The lysate preparation was loaded onto a cobalt metal affinity column, 
HisPur, washed to remove contaminants, and eluted in 20 fractions with an imidazole 
concentration gradient.  Fractions containing the target protein were pooled and loaded onto an 
ion exchange column, HiTrap Q-HP for AC7 C2 or HiTrap SP-HP for AC7 C1a, washed to 
remove contaminants, and eluted in 50 fractions with a NaCl gradient.  Finally, fractions 
containing the target proteins were pooled and concentrated using an Amicon Ultra 10K filter by 
centrifugation at 4ºC, 4000rpm.  Protein quantity was measured by BCA protein assay kit or 
based on their molecular extinction coefficient and A280.   
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Enzymatic Activity Assay 
Our AC activity assay protocol used [α-32P] ATP as a substrate.  The total reaction 
contained 10-15μg of total purified protein (one C1a protein and one C2 protein combined), 
250μM ATP, 25mM Tris-HCl pH 7.4, 100μM IBMX, 10mM phosphocreatine, 5 U creatine 
phosphokinase, and [α-32P] ATP (50-80 cpm/pmol).  AC activity was stimulated with one or 
more of the following: MnCl2, forskolin, purified Gsα protein, or forskolin analogue NKH477.  
Reaction mixtures were prepared on ice and the assay was initiated by temperature-shift to 30°C 
for 15min.  The reaction was terminated by the addition of a solution containing 2% SDS, 1mM 
ATP, and 1mM cAMP.  
3
H cAMP was added as an internal control to estimate the recovery of 
cAMP.  Sequential column chromatography by dowex 50 and neutral alumina columns was used 
to separate ATP and cAMP.  A liquid scintillation counter was used to quantify radioactivity in 
the final sample (Salomon, Londos, & Rodbell, 1974).   
Data Analysis 
 All assay data were acquired in triplicate and each experiment performed at least twice to 
ensure reliability of measures.  Concentration response curve fitting was carried out by non-
linear regression analysis using either 3 or 4 parameter logistic equation: 
 
  
 
     
    
 
 
         
 
     
    
 
 
 
 
a: maximal value, b: Hill’s coefficient, x0: EC50, y0: minimal value. Statistical analysis was 
carried out by t-test.  Sigma Plot and Sigma Stat (Systat Software, Point Richmond, CA) were 
used to plot and analyze data. 
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Results 
 Our first objective was to test the effect of AC activators on AC7 C1a + AC7 C2 using 
several conditions of activators alone, or in combinations of two or all three.  Basal activity of 
AC7 C1a + AC7 C2 was also assayed for comparison.  As expected the AC activity under the 
basal condition was not significantly different from background levels and the forskolin 
condition resulted in very weak AC activation.  AC activation by forskolin generally requires co-
activation by another activator such as manganese or Gsα.  Gsα alone was a weak activator of 
AC activity and MnCl2 alone, MnCl2 + forskolin, and Gsα + forskolin showed intermediate 
activation.  MnCl2 + Gsα activation provided a high level of AC activity.  Finally, the 
combination of all three AC stimulators, MnCl2 + forskolin + Gsα appeared to have a synergistic 
effect on AC activity.  The presence of all three AC activators stimulated AC activity far greater 
than the sum of any of the other conditions.  Figure 4.1 presents the degree of variability between 
these conditions of AC activation; MnCl2 concentration is 2.5mM, forskolin concentration is 
10μM, and 8.5μg purified proteins per reaction. 
 Using the various combinations for AC activation, we next examined the effect of 
100mM butanol on AC activity.  The conditions for AC activation not only affected the 
magnitude of the alcohol effect, but also determined in the effect of alcohol was positive or 
negative on AC activity (Figure 4.2.).  The only conditions resulting in enhancement of AC 
activity were MnCl2 alone + 100mM BuOH or the combination of MnCl2 + forskolin + 100 mM 
BuOH.  All other combinations of AC activators resulted in AC inhibition when in the presence 
of 100mM BuOH, and the extent of inhibition varied depending on the combination of AC 
activators in the condition. 
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Figure 4.1. AC7 C1a + AC7 C2 activity under various conditions of AC activation (Mn = MnCl2, 
Fsk = forskolin, Gs = Gsα).    
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Figure 4.2.  Effect of 100mM butanol on AC7 C1a + AC7 C2 activity under various conditions of 
AC activation. 
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 Because many of these conditions resulted in the inhibition of AC activity when exposed 
to butanol, we designed an experiment to test the alcohol cutoff point for AC7 when activated by 
MnCl2, forskolin, and Gsα combined.  The observed inhibition was unexpected, and to test the 
validity of this observation, we needed to see if the inhibition followed the same alcohol cutoff 
seen in native AC7 and recombinant AC7sol.  AC activity was activated using MnCl2, forskolin, 
and Gsα; activity was assayed in the presence of various concentrations of ethanol, butanol, 
pentanol, or hexanol.  Under these conditions, the potency of alcohol to inhibit AC activity 
increased until hexanol.  Inhibition of AC activity by hexanol was no greater than inhibition by 
pentanol, suggesting that the alcohol cutoff was pentanol (Figure 4.3.).  This is consistent with 
our previous observations in native AC7 and AC7sol and provides rationale for use of these AC 
activation conditions in concentration response studies of recombinant AC7. 
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Figure 4.3.  Determination of alcohol cutoff point for AC7 C1a + AC7 C2 activated by MnCl2, 
forskolin, and Gsα.  Alcohol cutoff point was pentanol. 
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 All studies were carried out under AC activation by MnCl2, forskolin, and Gsα.  The 
parameter determined was EC50, which stands for half maximal effective concentration.  EC50 is 
derived from a concentration response curve and indicates the concentration of a drug at which 
the response (AC activity) is midway between the baseline and maximum response.  The 
concentration of MnCl2 remained constant at 2.5mM; concentrations of forskolin and Gsα varied 
by experiment.  All experiments used butanol at concentrations ranging from 0-400mM.  Our 
first set of experiments explored the relationship between alcohol and forskolin and the resulting 
changes in EC50 of AC7 activity.   
A forskolin concentration-response experiment was performed using forskolin 
concentrations of 1, 10, 25, 100, and 200µM; concentrations of 2.5mM MnCl2, 4µg Gsα 
remained constant, and experiments were carried out in the absence or presence of 100mM 
BuOH.  The solubility of forskolin is limited in water or aqueous solution and the forskolin 
concentration-response regression curve did not reach a plateau (Figure 4.4.), and without 
knowing the effects of higher concentrations of forskolin we were not able to determine EC50 
accurately. 
  In order to address the solubility constraints of forskolin, we acquired a forskolin 
analogue, NKH 477, which is soluble in water at a maximum concentration of 40mM.  Using 
NKH 477, a concentration-response experiment was performed using concentrations of 10, 30, 
100, and 300µM, 1mM, and 3mM; concentrations of 2.5mM MnCl2, 4µg Gsα remained constant, 
and experiments were carried out in the absence or presence of 100mM BuOH.  EC50 was 
significantly shifted right by butanol, meaning the potency of forskolin decreased (Figure 4.5.). 
 To test the effect of forskolin on the butanol effect, we performed a concentration-response 
experiment using concentrations of butanol ranging from 0-400mM while keeping the forskolin 
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Figure 4.4. Forskolin concentration response curve for AC7 C1a + AC7 C2 in the presence or 
absence of 100mM butanol.  Because of forskolin solubility restraints, maximum response was 
not achievable and the EC50 value was not valid.  EC50 (-) BuOH 786.5 ± 854.5 mM, EC50 (+) 
BuOH 59.1 ± 9.3 mM, P = 0.405. 
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Figure 4.5.  Forskolin analogue, NKH477 concentration response curve for AC7 C1a + AC7 C2 in 
the presence or absence of 100mM butanol.  EC50 value was significantly different in the 
presence of butanol.  EC50 (-) BuOH 533.6 ± 26.8 M, EC50 (+) BuOH 659.1 ± 52.9 M, P = 
0.044 
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concentration constant at 25µM.  In this experiment, the addition of forskolin appeared to 
enhance the potency of BuOH (Figure 4.6.) and EC50 was significantly shifted left by forskolin. 
The effect of butanol on AC activation by Gsα was examined next.  We performed a 
concentration-response experiment essentially modifying the extent to which Gsα is activated in 
the reaction.  Concentrations of GppNHp 0, 0.5, 3, 5, 10, and 50µM were used in the activation 
of Gsα; the actual quantity of Gsα protein remained constant at 4µg per reaction, along with 
2.5mM MnCl2 and 25µM forskolin.  The presence of butanol did decrease AC activity (Figure 
4.7.), however, EC50 of GppNHp was not significantly affected by butanol.   
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Figure 4.6.  Butanol concentration response curve for AC7 C1a + AC7 C2 in the presence or 
absence of 25μM forskolin.  EC50 value was significantly different in the presence of forskolin.  
EC50 (-) forskolin 188.6 ± 9.8 mM, EC50 (+) forskolin 100.5 ± 6.3 mM, P <0.001. 
62 
 
GppNHp Concentration (M)
1 10 100
A
C
 A
c
ti
v
it
y
 (
p
m
o
l/
m
g
*m
in
)
0
2000
4000
6000
8000
10000
- BuOH 
+ BuOH 
 
Figure 4.7.  GppNHp concentration response curve for AC7 C1a + AC7 C2 in the presence or 
absence of 100mM butanol.  EC50 value was not significantly different in the presence of 
butanol.  EC50 (-) BuOH 4.3 ± 0.2 (M), EC50 (+) BuOH 4.1 ± 0.5 (M), P = 0.667. 
 
 To test the effect of Gsα on potency of butanol, we performed a concentration-response 
experiment using concentrations of butanol ranging from 0-400mM in the presence or absence of 
Gsα.  EC50 for butanol shifted left significantly in the presence of Gsα (Figure 4.8.). 
Discussion 
 It is important to place in context the response of our purified recombinant AC7 to 
alcohol under some of our experimental conditions.  First, let us point out that these experiments 
are designed as pharmacological tools for understanding the biochemical mechanisms involved 
in the interaction between AC and alcohol and are not intended to replicate a physiologically 
relevant system.  The use of butanol and other alcohols which are not subject to human use are 
only meant to provide a tool for accentuating the response of AC to the alcohol.  By accentuating 
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Figure 4.8.  Butanol concentration response curve for AC7 C1a + AC7 C2 in the presence or 
absence of 4μg Gsα.  EC50 value was significantly different in the presence of Gsα.  EC50 (-) 
Gsα 334.7  ± 22.8 mM, EC50 (+) Gsα 113.4  ± 4.9 mM, P <0.001. 
 
the AC response to alcohol we are provided with greater flexibility in manipulating the AC 
response with other AC modulators such as MnCl2, forskolin, and Gsα. 
 Under conditions with multiple AC activators, the effect of alcohol on AC7 appears to 
reverse from enhancement of AC activity to inhibition of AC activity.  There are several 
potential explanations for this inhibition.  As discussed, the use of multiple AC activators, 
especially drugs that are not endogenous activators of AC, may result in a conformational 
organization that does not normally occur in vivo.  This may be the explanation for the high AC 
activity observed when MnCl2, forskolin, and Gsα are used together to activate AC.  
Furthermore, while our chimeric studies determined that the membrane-spanning domains were 
not required for the alcohol effect on AC, they may provide an anchor to ensure that the AC 
structure maintains the appropriate conformation.  Outside of the constraints of the membrane or 
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covalent linkage indicated for AC7sol, our purified recombinant AC may exist in a slightly 
altered conformation or alcohol may cause conformational changes different from that in native 
AC7 or AC7sol.  In fact, AC7sol also exhibited inhibition by alcohol under activation conditions 
containing Gsα or Gsα + forskolin. 
 To ensure that this novel observation of inhibition of AC activity by alcohol did not 
negate our previous findings, we designed an alcohol cutoff experiment to test if the inhibition 
still followed the same alcohol cutoff as in previous studies where alcohol enhanced AC activity.  
Under the condition of AC activation by MnCl2, forskolin, and Gsα, in which the activity of AC 
and effect of alcohol were both highest, we examined the effect of various concentrations of n-
alkanols: ethanol, butanol, pentanol, and hexanol.  This experiment found that pentanol was the 
alcohol cutoff point for AC7 C1a + C2 under these conditions; the inhibition of AC activity grew 
more potent with increasing n-alkanols up to pentanol, beyond pentanol there was no further 
increase in inhibition.  These results suggest that the fundamental interaction of AC and alcohol 
remains the same regardless if the effect of alcohol is inhibition or enhancement of AC activity.  
Thus, we determined that the use of these AC activation conditions by MnCl2, forskolin, and Gsα 
would be a valid means for performing a concentration response study in an effort to uncover a 
potential interaction mechanism for alcohol and AC. 
 The result showing that the alcohol effect is dependent on the combination of AC 
activators suggests that one of these activators and alcohol may be acting allosterically in the 
regulation of AC activity.  Initially, we suspected that alcohol might be competing with either 
forskolin or Gsα for an allosteric site; essentially interfering with the ability of forskolin or Gsα 
to enhance AC activity.  However, our data did not support that hypothesis.  Instead, the data 
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suggests that butanol slightly decreased the potency of forskolin while having no effect on the 
potency of Gsα.  
 The regulation of AC by forskolin and alcohol was measured in two ways.  
Concentration-response curves were generated for forskolin (analogue NKH477) in the presence 
or absence of 100mM butanol and butanol response curves in the presence or absence of 25µM 
forskolin.  The forskolin concentration-response curve suggests that addition of butanol shifts the 
curve to the right, thus decreases the potency of NKH477.  The butanol concentration-response 
curve indicated that addition of forskolin did increase the potency of butanol on AC activity. 
 The regulation of AC by Gsα and alcohol was measured in two ways.  Rather than 
shifting the concentration of Gsα in a concentration-response curve, we shifted the concentration 
of the G protein activator, GppNHp.  The concentration-response experiment with GppNHp 
essentially controls the concentration of active Gsα in the reaction.  There was no significant 
change in the EC50 value for GppNHp suggesting that alcohol does not affect the potency of 
Gsα.  In the second experiment, a concentration-response curve was generated for butanol in the 
presence or absence of Gsα activated by 20µM GppNHp.  This experiment suggests that Gsα 
does enhance the effect of butanol on AC activity.  Furthermore, comparing to forskolin the 
effect of Gsα on the butanol effect is much greater (>3fold change in EC50) under the conditions 
used. 
 These results suggest that there are some interactions between alcohol and forskolin or 
Gsα, however, in comparison to the magnitude of the alcohol effect they are minor.  The 
observed inhibitory effect of alcohol when AC is activated by MnC12 + forskolin + Gsα is not 
due to the change in binding affinity of forskolin or Gsα.  It appears that the alcohol effect is 
directly on AC molecules causing conformational changes resulting in inhibition and mainly 
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independent of the activator (forskolin or Gsα) effect.  Future kinetic studies will determine the 
effect of alcohol on Km and Vmax as determined for AC7sol. 
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CHAPTER 5. 
CONCLUDING REMARKS 
 
Overall Summary of Findings 
 Ample research has established an effect of alcohol on the cAMP cell signaling system.  
Changes to cAMP signaling following alcohol exposure have been observed in clinical alcoholic 
patients as well as experimental animal models of alcohol use (Diamond, Wrubel, Estrin, & 
Gordon, 1987; Nagy, Diamond, & Gordon, 1988; Kirstein & Tabakoff, 2001; Donohue, 
Hoffman, & Tabakoff, 2005)     Furthermore, a specific component of cAMP signaling, adenylyl 
cyclase has been proposed as the direct target of the alcohol effect on cAMP signaling 
(Menninger, Baron, & Tabakoff, 1998; Menninger et al., 2000; Maas, Jr. et al., 2005; Kim, Kim, 
Baek, Lee, & Han, 2011; Morales-Mulia et al., 2012).  The primary objective in our laboratory 
has been to characterize the effect of alcohol on adenylyl cyclase at the molecular level.  Thus 
far, our lab has established that the alcohol effect is isoform specific with AC7 most enhanced by 
ethanol and ethanol responsive domains are located in the cytoplasmic regions of the AC protein 
(Yoshimura & Tabakoff, 1995; Yoshimura & Tabakoff, 1999; Yoshimura, Pearson, Kadota, & 
Gonzalez, 2006; Kou & Yoshimura, 2007; Hasanuzzaman & Yoshimura, 2010; Gupta, Qualls-
Creekmore, & Yoshimura, 2013).  We have also generated a recombinant AC protein, AC7sol, 
containing only the cytoplasmic regions of AC7, and characterized the alcohol effect on this 
protein in a bacterial lysate preparation (Dokphrom, Qualls-Creekmore, & Yoshimura, 2011).  
The current study expanded the design of recombinant AC to include isoforms AC2 and AC9, 
and optimized conditions for the expression and purification of these proteins.  The purification 
of AC constructs allowed us the ability to study the biochemical mechanism of the alcohol effect 
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on AC in a manner not previously possible in our other model systems, such as live cells 
transfected with specific components of cAMP signaling system.  
 In chapter 2, we designed recombinant proteins derived from mammalian AC including 
AC2sol, AC7sol, AC7 C1a, AC7 C2, AC2 C1a, AC2 C2, AC9 C1a, and AC9 C2.  We optimized the 
expression of these recombinant proteins through manipulations in expression conditions 
including choice of plasmid vector, E. coli cell line for expression, culture growth medium, 
growing conditions for temperature, time, and agitation speed, cell growth density (A600) at time 
of protein expression induction by IPTG, and concentration of IPTG used for induction.  We 
optimized the purification of our recombinant AC proteins by modifying our choice of affinity 
chromatography column and elution conditions.  We determined that the optimal condition were 
the use of pQE82L plasmid vector, transformation in BL21 (DE3) E. coli cell line, culture 
growth in T7 medium with induction at A600 = 0.6 with 100µM IPTG and continued culture 
growth at 25ºC, 100rpm, for 19hr.  The optimal protein purification protocol included the use of 
a cobalt metal affinity column, HisPur (by Pierce), with the addition of selected protease 
inhibitors to all working buffers and glycerol in the elution buffer, followed by ion exchange 
chromatography.  The expression and purity of each recombinant protein was visualized by SDS-
PAGE analysis.  Ultimately, AC2sol and AC7sol did not achieve sufficient expression to warrant 
further enzymatic analysis.  All other recombinant AC proteins, with the exception of AC2 C1a, 
were expressed and purified to a quality acceptable for further analysis. 
 In chapter 3, we examined the AC activity of our various AC recombinant proteins.  
Through analysis of our primary isoform of interest, AC7, we found that the separate expression 
and purification of the cytoplasmic regions of AC can be combined to reconstitute catalytic 
activity in vitro.  Our use of purified protein confirms that the alcohol effect is not reliant upon 
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any other proteins.  We provided support for our previous work indicating that the alcohol 
response of AC is isoform specific.  Through chimeric combinations of AC C1a and C2 regions, 
we were able to determine that the AC7 C1a region contributes more strongly to the AC alcohol 
effect than does AC7 C2. 
 In chapter 4, we measured the response of AC7 C1a + AC7 C2 to alcohol under various 
conditions of AC activation.  Concentration-response curves were generated for butanol in the 
presence or absence of forskolin and Gsα.  Dose-response curves were also generated for 
forskolin and Gsα in the presence or absence of butanol.  Our initial expectation was that alcohol 
was competing with Gsα or forskolin, leading to the inhibition observed when AC is activated by 
MnCl2 + forskolin + Gsα in the presence of alcohol.  However, the dose-response experiments 
suggest that there is no competition for binding sites between alcohol and either forskolin or 
Gsα.  While there are some interactions between alcohol and forskolin/Gsα, these interactions 
are minor and not likely the cause of the AC inhibition observed in the presence of alcohol.  It 
seems that alcohol interacts with AC protein directly and causes conformational changes 
resulting in either enhancement or inhibition depending on the stimulators present. 
Significance of Research 
 Adenylyl cyclase is a key component of the cAMP signaling system.  cAMP signaling 
initiates many cellular events including gene expression, cell growth, myocardial contraction, 
cytokine production, glycolysis, fatty acid metabolism, and is also implicated in learning and 
memory.  It is possible that the effect of alcohol on AC may have downstream effects on any of 
these cAMP-linked functions.  Therefore, understanding how alcohol affects AC may also help 
to explain many of the physiological consequences of alcohol use in both acute and chronic 
exposure. 
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 While research on the clinical and experimental effects of alcohol use continues to 
expand, there remains a great deal of unknown when it comes to the specific biochemical effect 
of alcohol.  Much of the research remains at the observational/descriptive level.  A few research 
groups have investigated the specific mechanism of action for alcohol within the cell.  Crystal 
structures have been resolved for LUSH, an odorant binding protein in Drosophila responsible 
for detecting alcohol, in complex with ethanol, propanol, and butanol (Kruse, Zhao, Smith, & 
Jones, 2003).  Other structural studies have suggested alcohol binding sites on ion channels 
(Howard et al., 2011), but these studies have used much larger, synthetic types of alcohol.  While 
many descriptive studies have indicated a role for AC in the alcohol response, ours is the first to 
attempt to understand the direct interaction between AC and alcohol.  We are the first to ever 
investigate the effects of alcohol on purified AC.  Identifying the AC regions required for the 
alcohol effect can help reveal a mechanism for how alcohol affects protein function.  While our 
current studies do not provide the definitive answers provided by structural analysis, we have 
been able to narrow down the potential sites for alcohol action on AC.  There are not many direct 
alcohol binding mechanisms known, and the interaction between alcohol and AC could represent 
a new alcohol binding motif.  Ultimately, elucidating the mechanism through which alcohol 
interacts with AC will have great implications for the field of alcohol research and may lead to 
the development of clinical tools for the diagnosis and treatment of alcohol-related disorders.    
Future Directions 
 The results presented here provide clear evidence for the direct effect of alcohol on AC 
within the constraints of the cytoplasmic domains, C1a and C2.  However, the exact location of 
alcohol interaction with AC cannot be determined from these data.  Additional kinetic studies 
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will be performed to determine the effect of alcohol on Km and Vmax.  The kinetic values will 
determine any effect of alcohol on the binding of AC substrate ATP.   
 The next milestone in this research will be the attainment of structural data for the 
interaction of AC with alcohol.  The primary limiting factor for the accomplishment of this step 
is the expression and purification of the target protein.  Structural analysis requires not only pure 
protein, but also a high concentration of protein.  To date in our lab, we have attempted structural 
analysis of an AC/alcohol complex through nuclear magnetic resonance (NMR) spectroscopy 
and circular dichroism (CD).  NMR uses the magnetic properties of atoms to make inferences 
about the structure of the protein.  CD measures the absorption of circularly polarized light to 
make inferences about the secondary structure of the protein and can measure changes in that 
structure under different conditions.  We have experimented with both NMR and CD in our lab.  
Preliminary data has been obtained by NMR which was capable of resolving the structure of 
AC7 C2, observing a folded and monomeric protein.  However, successive attempts to reproduce 
this data in the presence of alcohol have not been productive.  CD analysis was carried out on 
AC7 C1a + AC7 C2 alone in a buffer solution and under AC activation conditions of MnCl2 and 
MnCl2 + ethanol.  We were able to resolve a CD profile with relatively low background noise.  
Differential CD profiles were observed between the protein complex alone and with MnCl2 
added, however, no clear difference was detected with the addition of ethanol.  Successful 
analysis at the structural level will require a more highly expressed protein and increased 
homogeneity of the sample, especially in the case of AC7 C1a, which remains a challenge.  
Additional measures of purification are planned, including size-exclusion chromatography and a 
more sophisticated ion-exchange chromatography.  However, it is also important to minimize the 
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exposure of the protein during purification in order to maintain the enzymatic integrity of the 
protein. 
In conclusion, these studies have provided the means for examining the effect of alcohol 
on purified adenylyl cyclase proteins.  We have begun to narrow down the potential mechanisms 
for alcohol-AC interaction and have paved the way for future structural studies that may have the 
capability to resolve the exact binding motif for alcohol on adenylyl cyclase. 
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